(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
☒ | Smaller reporting company | |||
Accelerated filer | ☐ | Emerging growth company | ||
Non-accelerated filer | ☐ |
Page | ||
Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025 .......................................................... | ||
Consolidated Financial Statements for the Three Months Ended March 31, 2026 and 2025: | ||
Consolidated Statements of Operations ................................................................................................................... | ||
Consolidated Statements of Comprehensive Income ............................................................................................ | ||
Consolidated Statements of Changes in Stockholders’ Equity and Noncontrolling Interests .......................... | ||
Consolidated Statements of Cash Flows ................................................................................................................ | ||
Notes to Consolidated Financial Statements .................................................................................................................... | ||
OPERATIONS ........................................................................................................................................................................ | ||
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK ......................................................... | ||
CONTROLS AND PROCEDURES ..................................................................................................................................... | ||
LEGAL PROCEEDINGS ...................................................................................................................................................... | ||
RISK FACTORS .................................................................................................................................................................... | ||
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS ................................................... | ||
OTHER INFORMATION ....................................................................................................................................................... | ||
EXHIBITS ............................................................................................................................................................................... | ||
SIGNATURES ................................................................................................................................................................................................. | ||
ASU | Accounting Standards Update |
ATM | At the Market |
CAD | Canadian Dollar |
CIP | Construction in Progress |
EPS | Earnings per Share |
FASB | Financial Accounting Standards Board |
FFO | Funds From Operations |
GAAP | U.S. Generally Accepted Accounting Principles |
IRS | Internal Revenue Service |
JV | Joint Venture |
Nareit | National Association of Real Estate Investment Trusts |
NAV | Net Asset Value |
NYSE | New York Stock Exchange |
REIT | Real Estate Investment Trust |
RSF | Rentable Square Feet/Foot |
SEC | Securities and Exchange Commission |
SF | Square Feet/Foot |
SoDo | South of Downtown submarket of Seattle |
SOFR | Secured Overnight Financing Rate |
U.S. | United States |
USD | U.S. Dollar |
VIE | Variable Interest Entity |

March 31, 2026 | December 31, 2025 | ||
(Unaudited) | |||
Assets | |||
Investments in real estate | $ | $ | |
Investments in unconsolidated real estate joint ventures | |||
Cash and cash equivalents | |||
Restricted cash | |||
Tenant receivables | |||
Deferred rent | |||
Deferred leasing costs | |||
Investments | |||
Other assets | |||
Total assets | $ | $ | |
Liabilities, Noncontrolling Interests, and Equity | |||
Unsecured senior notes payable | $ | $ | |
Unsecured senior line of credit and commercial paper | |||
Accounts payable, accrued expenses, and other liabilities | |||
Dividends payable | |||
Total liabilities | |||
Commitments and contingencies | |||
Redeemable noncontrolling interests | |||
Alexandria Real Estate Equities, Inc.’s stockholders’ equity: | |||
Common stock | |||
Additional paid-in capital | |||
Accumulated other comprehensive loss | ( | ( | |
Alexandria Real Estate Equities, Inc.’s stockholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities, noncontrolling interests, and equity | $ | $ |

Three Months Ended March 31, | |||
2026 | 2025 | ||
Revenues: | |||
Income from rentals | $ | $ | |
Other income | |||
Total revenues | |||
Expenses: | |||
Rental operations | |||
General and administrative | |||
Interest | |||
Depreciation and amortization | |||
Impairment of real estate | |||
Total expenses | |||
Equity in losses of unconsolidated real estate joint ventures | ( | ( | |
Investment loss | ( | ( | |
Gain on early extinguishment of debt | |||
Gain on sales of real estate | |||
Net income | |||
Net income attributable to noncontrolling interests | ( | ( | |
Net income (loss) attributable to Alexandria Real Estate Equities, Inc.’s stockholders | ( | ||
Net income attributable to unvested restricted stock awards | ( | ( | |
Net income (loss) attributable to Alexandria Real Estate Equities, Inc.’s common stockholders | $ | $( | |
Net income (loss) per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders: | |||
Basic | $ | $( | |
Diluted | $ | $( | |

Three Months Ended March 31, | |||
2026 | 2025 | ||
Net income | $ | $ | |
Other comprehensive (loss) income | |||
Change in foreign currency translation adjustments: | |||
Unrealized foreign currency translation (losses) gains arising during the period | ( | ||
Reclassification of gains | ( | ||
Unrealized (losses) gains on foreign currency translation, net | ( | ||
Total other comprehensive (loss) income | ( | ||
Comprehensive income | |||
Less: comprehensive income attributable to noncontrolling interests | ( | ( | |
Comprehensive income (loss) attributable to Alexandria Real Estate Equities, Inc.’s stockholders | $ | $( | |

Alexandria Real Estate Equities, Inc.’s Stockholders’ Equity | ||||||||||||||||
Number of Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | |||||||||
Balance as of December 31, 2025 | $ | $ | $ | $( | $ | $ | $ | |||||||||
Net income | — | — | — | — | ||||||||||||
Total other comprehensive loss | — | — | — | — | ( | — | ( | — | ||||||||
Contributions from and sales of noncontrolling interests | — | — | — | — | — | |||||||||||
Distributions to and redemption of noncontrolling interests | — | — | — | — | ( | ( | ( | |||||||||
Issuance pursuant to stock plan | — | — | — | — | ||||||||||||
Taxes related to net settlement of equity awards | ( | ( | ( | — | — | — | ( | — | ||||||||
Dividends declared on common stock ($ | — | — | — | ( | — | — | ( | — | ||||||||
Reclassification of earnings in excess of distributions | — | — | ( | — | — | — | ||||||||||
Balance as of March 31, 2026 | $ | $ | $ | $( | $ | $ | $ | |||||||||

Alexandria Real Estate Equities, Inc.’s Stockholders’ Equity | ||||||||||||||||
Number of Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | |||||||||
Balance as of December 31, 2024 | $ | $ | $ | $( | $ | $ | $ | |||||||||
Net (loss) income | — | — | — | ( | — | |||||||||||
Total other comprehensive income | — | — | — | — | — | — | ||||||||||
Contributions from and sales of noncontrolling interests | — | — | — | — | — | |||||||||||
Distributions to and redemption of noncontrolling interests | — | — | ( | — | — | ( | ( | ( | ||||||||
Issuance pursuant to stock plan | — | — | — | — | ||||||||||||
Taxes related to net settlement of equity awards | ( | ( | — | — | — | ( | — | |||||||||
Repurchase of common stock | ( | ( | ( | — | — | — | ( | — | ||||||||
Dividends declared on common stock ($ | — | — | — | ( | — | — | ( | — | ||||||||
Reclassification of distributions and net loss | — | — | ( | — | — | — | ||||||||||
Balance as of March 31, 2025 | $ | $ | $ | $( | $ | $ | $ | |||||||||

Alexandria Real Estate Equities, Inc. Consolidated Statements of Cash Flows (In thousands) (Unaudited) | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Operating Activities: | |||
Net income | $ | $ | |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | |||
Impairment of real estate | |||
Gain on sales of real estate | ( | ||
Gain on early extinguishment of debt | ( | ||
Equity in losses of unconsolidated real estate joint ventures | |||
Distributions of earnings from unconsolidated real estate joint ventures | |||
Amortization of loan fees | |||
Amortization of debt discounts | |||
Amortization of acquired above- and below-market leases | ( | ( | |
Deferred rent | ( | ( | |
Stock compensation expense | |||
Investment loss | |||
Changes in operating assets and liabilities: | |||
Tenant receivables | ( | ( | |
Deferred leasing costs | ( | ( | |
Other assets | ( | ( | |
Accounts payable, accrued expenses, and other liabilities | ( | ( | |
Net cash provided by operating activities | |||
Investing Activities: | |||
Proceeds from sales of real estate | |||
Additions to real estate | ( | ( | |
Change in escrow deposits | ( | ||
Investments in unconsolidated real estate joint ventures | ( | ( | |
Return of capital from unconsolidated real estate joint ventures | |||
Additions to non-real estate investments | ( | ( | |
Sales of and distributions from non-real estate investments | |||
Net cash used in investing activities | $( | $( | |

Alexandria Real Estate Equities, Inc. Consolidated Statements of Cash Flows (In thousands) (Unaudited) | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Financing Activities: | |||
Borrowings under secured note payable | $ | $ | |
Repayments of borrowings under secured notes payable | ( | ||
Proceeds from issuance of unsecured senior notes payable | |||
Repayment of unsecured senior notes payable | ( | ||
Proceeds from issuances under commercial paper program | |||
Repayments of borrowings under commercial paper program | ( | ( | |
Payments of loan fees | ( | ( | |
Taxes paid related to net settlement of equity awards | ( | ( | |
Repurchase of common stock | ( | ||
Dividends on common stock | ( | ( | |
Contributions from and sales of noncontrolling interests | |||
Distributions to noncontrolling interests | ( | ( | |
Purchases and redemptions of noncontrolling interests | ( | ( | |
Net cash provided by financing activities | |||
Effect of foreign exchange rate changes on cash and cash equivalents | ( | ( | |
Net decrease in cash, cash equivalents, and restricted cash | ( | ( | |
Cash, cash equivalents, and restricted cash as of the beginning of period | |||
Cash, cash equivalents, and restricted cash as of the end of period | $ | $ | |
Supplemental Disclosure and Non-Cash Investing and Financing Activities: | |||
Cash paid during the period for interest, net of interest capitalized | $ | $ | |
Accrued construction for current-period additions to real estate | $ | $ | |
Transfer of real estate assets and/or equipment from tenants | $ | $ | |
Notes receivable issued in connection with sales of real estate | $ | $ | |
Derecognition of net investment in real estate from sales-type lease | $ | $ | |
Acquisition of real estate and other assets in connection with assumption of related secured notes payable of unconsolidated joint venture | $ | $ | |







Three Months Ended March 31, | ||||
2026 | 2025 | |||
Income from rentals: | ||||
Revenues subject to the lease accounting standard: | ||||
Operating leases | $ | $ | ||
Direct financing and sales-type leases | ||||
Revenues subject to the lease accounting standard | ||||
Revenues subject to the revenue recognition accounting standard | ||||
Income from rentals | ||||
Other income | ||||
Total revenues | $ | $ | ||







March 31, 2026 | December 31, 2025 | |||
Rental properties: | ||||
Land (related to rental properties) | $ | $ | ||
Buildings and building improvements | ||||
Other improvements | ||||
Rental properties | ||||
Current and future development and redevelopment projects | ||||
Gross investments in real estate | ||||
Less: accumulated depreciation | ( | ( | ||
Investments in real estate assets held for sale, less accumulated depreciation(1) | ||||
Investments in real estate | $ | $ |
March 31, 2026 | December 31, 2025 | ||
Investments in real estate, less accumulated depreciation | $ | $ | |
Other assets | |||
Total assets | |||
Total liabilities | ( | ( | |
Total accumulated other comprehensive loss | ( | ( | |
Net assets classified as held for sale | $ | $ |


Property(1) | Market | Submarket | Our Ownership Interest | ||||||
Consolidated real estate joint ventures: | |||||||||
50 and 60 Binney Street | Greater Boston | Cambridge/Inner Suburbs | |||||||
75/125 Binney Street | Greater Boston | Cambridge/Inner Suburbs | |||||||
100 and 225 Binney Street and 300 Third Street | Greater Boston | Cambridge/Inner Suburbs | |||||||
15 Necco Street | Greater Boston | Seaport Innovation District | |||||||
Alexandria Center® for Science and Technology – Mission Bay(2) | San Francisco Bay Area | Mission Bay | |||||||
211 and 213 East Grand Avenue | San Francisco Bay Area | South San Francisco | |||||||
500 Forbes Boulevard | San Francisco Bay Area | South San Francisco | |||||||
Alexandria Center® for Life Science – Millbrae | San Francisco Bay Area | South San Francisco | |||||||
3215 Merryfield Row | San Diego | Torrey Pines | |||||||
Campus Point by Alexandria(3) | San Diego | University Town Center | (4) | ||||||
5200 Illumina Way | San Diego | University Town Center | |||||||
9625 Towne Centre Drive | San Diego | University Town Center | |||||||
SD Tech by Alexandria(5) | San Diego | Sorrento Mesa | |||||||
Summers Ridge Science Park(6) | San Diego | Sorrento Mesa | |||||||
1201 and 1208 Eastlake Avenue East | Seattle | Lake Union | |||||||
400 Dexter Avenue North | Seattle | Lake Union | |||||||
800 Mercer Street | Seattle | Lake Union | |||||||
Unconsolidated real estate joint ventures: | |||||||||
1655 and 1725 Third Street | San Francisco Bay Area | Mission Bay | |||||||
101 West Dickman Street | Maryland | Beltsville | (7) | ||||||

Property | Consolidation Model | Voting Interest | Consolidation Analysis | Conclusion | |||||
50 and 60 Binney Street | VIE model | Not applicable under VIE model | Consolidated | ||||||
75/125 Binney Street | We have: | ||||||||
100 and 225 Binney Street and 300 Third Street | |||||||||
15 Necco Street | (i) | The power to direct the activities of the joint venture that most significantly affect its economic performance; and | |||||||
Alexandria Center® for Science and Technology – Mission Bay | |||||||||
211 and 213 East Grand Avenue | |||||||||
500 Forbes Boulevard | |||||||||
Alexandria Center® for Life Science – Millbrae | (ii) | Benefits that can be significant to the joint venture. | |||||||
3215 Merryfield Row | |||||||||
Campus Point by Alexandria | |||||||||
5200 Illumina Way | Therefore, we are the primary beneficiary of each VIE | ||||||||
9625 Towne Centre Drive | |||||||||
SD Tech by Alexandria | |||||||||
Summers Ridge Science Park | |||||||||
1201 and 1208 Eastlake Avenue East | |||||||||
400 Dexter Avenue North | |||||||||
800 Mercer Street | |||||||||
101 West Dickman Street | We do not control the joint venture and are therefore not the primary beneficiary. | Equity method of accounting | |||||||
1655 and 1725 Third Street | Voting model | Does not exceed 50% | Our voting interest is 50% or less. | ||||||

March 31, 2026 | December 31, 2025 | |||
Investments in real estate | $ | $ | ||
Cash and cash equivalents | ||||
Other assets | ||||
Total assets | $ | $ | ||
Secured note payable | $ | $ | ||
Other liabilities | ||||
Total liabilities | ||||
Redeemable noncontrolling interests | ||||
Alexandria Real Estate Equities, Inc.’s share of equity | ||||
Noncontrolling interests’ share of equity | ||||
Total liabilities and equity | $ | $ |
Property | March 31, 2026 | December 31, 2025 | ||
1655 and 1725 Third Street | $ | $ | ||
101 West Dickman Street | ||||
Other | ||||
$ | $ |
Interest Rate(1) | At 100% | Our Share | ||||||||||||
Unconsolidated Joint Venture | Maturity Date | Stated Rate | Aggregate Commitment | Debt Balance(2) | ||||||||||
101 West Dickman Street | SOFR+ | (3) | $ | $ | ||||||||||
1655 and 1725 Third Street | ||||||||||||||
$ | $ | |||||||||||||

Year | Amount | |
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
Thereafter | ||
Total | $ |

March 31, 2026 | December 31, 2025 | ||
Gross investment in direct financing and sales-type leases | $ | $ | |
Less: unearned income on direct financing lease | ( | ( | |
Less: provision for expected credit losses | ( | ( | |
Net investment in leases | $ | $ |
Year | Total | |
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
Thereafter | ||
Total | $ |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Income from rentals: | ||||
Revenues subject to the lease accounting standard: | ||||
Operating leases | $ | $ | ||
Direct financing and sales-type leases | ||||
Revenues subject to the lease accounting standard | ||||
Revenues subject to the revenue recognition accounting standard | ||||
Income from rentals | $ | $ | ||


Year | Total | |
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
Thereafter | ||
Total future payments under our operating leases in which we are the lessee | ||
Effect of discounting | ( | |
Operating lease liability | $ |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Gross operating lease costs | $ | $ | ||
Capitalized lease costs | ( | ( | ||
Expenses for operating leases in which we are the lessee | $ | $ | ||
March 31, 2026 | December 31, 2025 | ||
Cash and cash equivalents | $ | $ | |
Restricted cash: | |||
Development escrows | |||
Security deposits | |||
Other | |||
Total | $ | $ |


March 31, 2026 | |||||||
Cost | Unrealized Gains | Unrealized Losses | Carrying Amount | ||||
Publicly traded companies | $ | $ | $( | $ | |||
Entities that report NAV | ( | ||||||
Entities that do not report NAV: | |||||||
Entities with observable price changes | ( | ||||||
Entities without observable price changes | |||||||
Investments accounted for under the equity method | N/A | N/A | N/A | ||||
Total investments | $ | $ | $( | $ | |||

December 31, 2025 | |||||||
Cost | Unrealized Gains | Unrealized Losses | Carrying Amount | ||||
Publicly traded companies | $ | $ | $( | $ | |||
Entities that report NAV | ( | ||||||
Entities that do not report NAV: | |||||||
Entities with observable price changes | ( | ||||||
Entities without observable price changes | |||||||
Investments accounted for under the equity method | N/A | N/A | N/A | ||||
Total investments | $ | $ | $( | $ | |||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Realized gains | $ | (1) | $ | |
Unrealized losses | ( | ( | ||
Investment loss | $( | (2) | $( | |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Investments in privately held entities that do not report NAV still held as of the end of each period: | ||||
Upward adjustments | $ | $ | ||
Downward adjustments and impairments | ( | ( | ||
$( | $( | |||
Unrealized gains (losses) on non-real estate investments still held as of the end of each period (excluding equity method investments) | $ | $( | ||

March 31, 2026 | December 31, 2025 | ||
Acquired in-place leases | $ | $ | |
Deferred compensation plan | |||
Deferred financing costs – unsecured senior line of credit | |||
Deposits | |||
Furniture, fixtures, equipment, and software | |||
Net investment in leases | |||
Notes receivable | |||
Operating lease right-of-use assets | |||
Other assets | |||
Prepaid expenses | |||
Property, plant, and equipment | |||
Total | $ | $ |
March 31, 2026 | ||||||||
Weighted-Average | ||||||||
Notes Receivable | Effective Interest Rate | Maturity Date | Balance | December 31, 2025 | ||||
Secured by real estate assets in San Diego | $ | $ | ||||||
Secured by real estate assets in Greater Boston | ||||||||
Less: provision for expected credit losses | ( | ( | ||||||
Notes receivable | $ | $ | ||||||

Fair Value Measurement Using | ||||||||
Description | Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | ||||
Assets: | ||||||||
Investments in publicly traded companies: | ||||||||
As of March 31, 2026 | $ | $ | $ | $ | ||||
As of December 31, 2025 | $ | $ | $ | $ | ||||
Cross-currency swap agreements: | ||||||||
As of March 31, 2026 | $ | $ | $ | $ | ||||
Liabilities: | ||||||||
Cross-currency swap agreements: | ||||||||
As of December 31, 2025 | $ | $ | $ | $ | ||||

Fair Value Measurement Using | ||||||||||
Description | Carrying Amount | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | ||||||
Real estate assets held for sale with carrying values adjusted to fair value less costs to sell: | ||||||||||
As of March 31, 2026 | $ | (1) | $ | $ | $ | (2) | ||||
As of December 31, 2025 | $ | (1) | $ | $ | $ | (2) | ||||
Investments in privately held entities that do not report NAV: | ||||||||||
As of March 31, 2026 | $ | $ | $ | (3) | $ | (4) | ||||
As of December 31, 2025 | $ | $ | $ | (3) | $ | (4) | ||||

March 31, 2026 | |||||||||
Book Value | Fair Value Hierarchy | Estimated Fair Value | |||||||
Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||
Liabilities: | |||||||||
Unsecured senior notes payable | $ | $ | $ | $ | $ | ||||
Unsecured senior line of credit | $ | $ | $ | $ | $ | ||||
Commercial paper program | $ | $ | $ | $ | $ | ||||
December 31, 2025 | |||||||||
Book Value | Fair Value Hierarchy | Estimated Fair Value | |||||||
Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||
Liabilities: | |||||||||
Unsecured senior notes payable | $ | $ | $ | $ | $ | ||||
Unsecured senior line of credit | $ | $ | $ | $ | $ | ||||
Commercial paper program | $ | $ | $ | $ | $ | ||||

Stated Rate | Interest Rate(1) | Maturity Date(2) | Principal Payments Remaining for the Periods Ending December 31, | Unamortized (Deferred Financing Cost), (Discount)/ Premium | ||||||||||||||||||||
Debt | 2026 | 2027 | 2028 | 2029 | 2030 | Thereafter | Principal | Total | ||||||||||||||||
Unsecured senior line of credit and commercial paper program(3) | (3) | (3) | (3) | $ | $ | $ | $ | $ | $ | $ | $( | $ | ||||||||||||
Unsecured senior notes payable | (4) | ( | ||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ||||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured debt weighted-average interest rate/Total | $ | $ | $ | $ | $ | $ | $ | $( | $ | |||||||||||||||

Fixed-Rate Debt | Variable-Rate Debt | Weighted-Average | ||||||||||
Interest | Remaining Term (in years) | |||||||||||
Total | Percentage | Rate(1) | ||||||||||
Unsecured senior notes payable | $ | $ | $ | |||||||||
Unsecured senior line of credit and commercial paper program | (2) | (2) | (3) | |||||||||
Total/weighted average | $ | $ | $ | (3) | ||||||||
Percentage of total debt | ||||||||||||

Three Months Ended March 31, | |||
2026 | 2025 | ||
Interest incurred | $ | $ | |
Capitalized interest | ( | ( | |
Interest expense | $ | $ | |
Balance Sheet Location | March 31, 2026 | December 31, 2025 | ||
Other assets | $ | $ | ||
Other liabilities | $ | $ |
Location in Consolidated Statement of Comprehensive Income | Three Months Ended March 31, 2026 | |||
Total unrealized gains recognized in other comprehensive income | Unrealized gains on foreign currency translation, net | $ |
Location in Consolidated Statement of Operations | Three Months Ended March 31, 2026 | |||
Total gain recognized in net income(1) | Other income | $ |

March 31, 2026 | December 31, 2025 | ||
Accounts payable and accrued expenses | $ | $ | |
Accrued construction | |||
Acquired below-market leases | |||
Conditional asset retirement obligations | |||
Deferred rent liabilities | |||
Operating lease liability | |||
Unearned rent and tenant security deposits | |||
Other liabilities | |||
Total | $ | $ |

Three Months Ended March 31, | |||
2026 | 2025 | ||
Net income | $ | $ | |
Net income attributable to noncontrolling interests | ( | ( | |
Net income attributable to unvested RSAs with nonforfeitable dividends | ( | ( | |
Numerator for basic and diluted EPS – net income (loss) attributable to Alexandria Real Estate Equities, Inc.’s common stockholders | $ | $( | |
Denominator for basic EPS – weighted-average shares of common stock outstanding | |||
Dilutive effect of unvested RSAs with forfeitable dividends | |||
Denominator for diluted EPS – weighted-average shares of common stock outstanding | |||
Net income (loss) per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders: | |||
Basic | $ | $( | |
Diluted | $ | $( | |


Three Months Ended March 31, | |||
2026 | 2025 | ||
Reportable segment revenues: | |||
Revenues from external customers | $ | $ | |
Other income | |||
Reportable segment total revenues | |||
Reportable segment total rental operating expenses | ( | ( | |
Reportable segment net operating income (reportable segment profit or loss) | $ | $ | |

Three Months Ended March 31, | |||
2026 | 2025 | ||
Reconciliation of reportable segment revenues to consolidated total revenues: | |||
Reportable segment total revenues | $ | $ | |
All other revenues | |||
Consolidated total revenues | $ | $ | |
Reconciliation of reportable segment total rental operating expenses to consolidated rental operations: | |||
Reportable segment total rental operating expenses | $( | $( | |
All other rental operating expenses | ( | ( | |
Consolidated rental operations | $( | $( | |
Reconciliation of reportable segment net operating income to consolidated net losses: | |||
Reportable segment net operating income (reportable segment profit or loss) | $ | $ | |
All other revenues | |||
All other rental operating expenses | ( | ( | |
Other items not allocated to segments: | |||
General and administrative | ( | ( | |
Interest expense | ( | ( | |
Depreciation and amortization | ( | ( | |
Impairment of real estate | ( | ( | |
Equity in losses of unconsolidated real estate joint ventures | ( | ( | |
Investment loss | ( | ( | |
Gain on early extinguishment of debt | |||
Gain on sale of real estate | |||
Consolidated net income | $ | $ | |
March 31, 2026 | December 31, 2025 | ||
Reconciliation of reportable segment assets to consolidated investments in real estate assets: | |||
Reportable segment investments in real estate | $ | $ | |
All other investments in real estate | |||
Consolidated investments in real estate | $ | $ |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Net income (loss) attributable to Alexandria’s common stockholders – diluted: | |||
In millions | $358.9 | $(11.6) | |
Per share | $2.10 | $(0.07) | |
Funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted: | |||
In millions | $295.9 | $392.0 | |
Per share | $1.73 | $2.30 | |
(As of March 31, 2026, unless stated otherwise) | ||||
Occupancy of operating properties | 87.7% | |||
Percentage of total annual rental revenue in effect from Megacampus platform | 78% | |||
Percentage of total annual rental revenue in effect from investment-grade or publicly traded large cap tenants | 55% | |||
Adjusted EBITDA margin for the three months ended March 31, 2026 | 66% | |||
Percentage of leases containing annual rent escalations | 97% | |||
Weighted-average remaining lease term: | ||||
Top 20 tenants | 9.9 | years | ||
All tenants | 7.5 | years | ||
Strong tenant collections(1): | ||||
Rents and receivables for the three months ended March 31, 2026, collected as of the date of this report | 99.9% |
Three Months Ended March 31, 2026 | ||
Leasing activity in RSF: | ||
Leasing of development and redevelopment space | 117,935 | |
Leasing of previously vacant space | 148,734 | |
Lease renewals and re-leasing of space | 380,687 | |
647,356 | ||
Lease renewals and re-leasing of space: | ||
Rental rate increase | (15.0)% | |
Rental rate increase (cash basis) | (15.8)% | |
(dollars in millions) | Sales Price | % | ||
Completed and pending transactions subject to non-refundable deposits, signed letters of intent, and/or sale agreement negotiations as of the date of this report | $151 | 5% | ||
Identified and in process | 2,181 | 75% | ||
Additional projected | 568 | 20% | ||
2026 guidance midpoint for dispositions and sales of partial interests | $2,900 |
Operating occupancy as of December 31, 2025 | 90.9% | ||
Reduction in occupancy related to previously disclosed key lease expirations during the three months ended March 31, 2026 | (1.9) | (1) | |
Other changes in occupancy | (1.3) | (2) | |
Operating occupancy as of March 31, 2026 | 87.7 | ||
Vacant space leased but not yet delivered | 3.2 | (3) | |
Operating occupancy as of March 31, 2026, including vacant space leased but not yet delivered | 90.9% |
Development and Redevelopment Projects | Incremental Annual Net Operating Income | RSF | Leased/ Negotiating Percentage | |||||
(dollars in millions) | ||||||||
Expected to be placed into service: | ||||||||
Second quarter of 2026 through fourth quarter of 2026 | $92 | (1) | 601,589 | (2) | 93% | (3) | ||
Fiscal years 2027 through 2028 | 93 | 1,258,004 | 68% | |||||
$185 | ||||||||
Revenue- and Non-Revenue- Enhancing Capital Expenditures | Tenant Improvements/ Leasing Commissions per RSF | Free Rent Concessions per Annum (leases executed in trailing 12 months) | Rental Rate Changes (on renewed/ re-leased spaces) | Operating Occupancy (as of each period end) | |||||
2024 | $273,377 | $46.89 | 0.7 months | 16.9% | 94.6% | ||||
2025 | $324,293 | $55.34 | 1.5 months | 7.0% | 90.9% | ||||
Three months ended March 31, 2026 | $164,382 | $59.92 | 2.0 months | (15.0)% | 87.7% | ||||
Midpoint of 2026 guidance range | $510,000 | N/A | (5.0)% | 87.0% | |||||
Aggregate Sales Price of Dispositions and Sales of Partial Interests | Impairment of Real Estate | Capitalization Rates(1) | Capitalization Rates (Cash Basis)(1) | ||||||
2024 | $1,382,453 | $223,068 | 7.7% | 6.5% | |||||
2025 | $1,813,778 | $2,202,818 | 7.7% | 7.5% | (2) | ||||
Three months ended March 31, 2026 | $— | $5,499 | N/A | ||||||
Midpoint of 2026 guidance range | $2,900,000 | (3) | |||||||
Unsecured Senior Notes Payable Issued | Interest Rate(1) | |||
2024 | $1,000,000 | 5.57% | ||
2025 | $550,000 | 5.66% | ||
February 2026 issuance | $750,000 | 5.41% |
Gross Interest Expense | Capitalized Interest | Interest Expense | ||||
2024 | $516,799 | $(330,961) | $185,838 | |||
2025 | $557,122 | $(330,424) | $226,698 | |||
Three months ended March 31, 2026 | $134,557 | $(69,973) | $64,584 | |||
Midpoint of 2026 guidance range | $505,000 | $(245,000) | $260,000 |
Non-Real Estate Investments | ||||||||||
Realized Gains | Significant Realized Losses | Impairments | Unrealized (Losses) Gains | Investment Loss | ||||||
2024 | $117,214 | $— | $(58,090) | $(112,246) | $(53,122) | |||||
2025 | $115,722 | $(103,329) | $(95,716) | $26,980 | $(56,343) | |||||
Three months ended March 31, 2026 | $18,198 | $— | $(12,448) | $(10,332) | $(4,582) | |||||
Midpoint of 2026 guidance range | $75,000 | N/A(1) | ||||||||
Same Property Performance: Net Operating Income Changes | Rental Rate Changes: Renewed/Re-Leased Space | |||||||||
Margins(3) | Favorable Lease Structure(4) | |||||||||
Operating | Adjusted EBITDA | Strategic Lease Structure by Owner and Operator of Collaborative Megacampus Ecosystems | ||||||||
67% | 66% | Increasing cash flows | ||||||||
Percentage of leases containing annual rent escalations | 97% | |||||||||
Stable cash flows | ||||||||||
Long-Duration Lease Terms(5) | Percentage of triple net leases | 91% | ||||||||
9.9 Years | 7.5 Years | Lower capex burden | ||||||||
Percentage of leases providing for the recapture of capital expenditures | 92% | |||||||||
Top 20 Tenants | All Tenants | |||||||||
Net Debt and Preferred Stock to Adjusted EBITDA(6) | Fixed-Charge Coverage Ratio(6) | |||||||||






Stable Cash Flows From Our High-Quality, Diverse Tenant Mix | |||
Investment-Grade or Publicly Traded Large Cap Tenants | |||
87% | 55% | ||
of ARE’s Top 20 Tenant Annual Rental Revenue | of ARE’s Total Annual Rental Revenue | ||


Three Months Ended | Year Ended | |||||||||
March 31, 2026 | December 31, 2025 | |||||||||
(Dollars per RSF) | Including Straight-Line Rent | Cash Basis | Including Straight-Line Rent | Cash Basis | ||||||
Leasing activity: | ||||||||||
Renewed/re-leased space(1) | ||||||||||
Rental rate changes | (15.0)% | (2) | (15.8)% | (2) | 7.0% | 3.5% | ||||
New rates | $49.88 | $53.43 | $52.71 | $53.66 | ||||||
Expiring rates | $58.67 | $63.42 | $49.27 | $51.87 | ||||||
RSF | 380,687 | 2,543,473 | ||||||||
Tenant improvements/leasing commissions | $59.92 | (2) | $55.34 | |||||||
Weighted-average lease term | 8.4 years | 9.0 years | ||||||||
Previously vacant/developed/redeveloped space leased | ||||||||||
New rates | $53.34 | $52.10 | $72.30 | $67.56 | ||||||
Previously vacant RSF | 148,734 | 944,362 | ||||||||
Developed/redeveloped RSF(3) | 117,935 | 704,821 | (4) | |||||||
Weighted-average lease term | 14.0 years | 13.8 years | ||||||||
Leasing activity summary (totals): | ||||||||||
New rates | $51.30 | $52.88 | $60.42 | $59.13 | ||||||
RSF | 647,356 | 4,192,656 | ||||||||
Weighted-average lease term | 12.0 years | 11.9 years | ||||||||
Lease expirations(1) | ||||||||||
Expiring rates | $56.43 | $62.28 | $54.22 | $55.56 | ||||||
RSF | 1,340,809 | (5) | 4,460,081 | |||||||
Year | RSF | Percentage of Occupied RSF | Annual Rental Revenue (per RSF)(1) | Percentage of Annual Rental Revenue | ||||||||||||||
2026 | (2) | 1,485,686 | 4.9% | $55.84 | 4.6% | |||||||||||||
2027 | 3,367,997 | 11.2% | $56.51 | 10.5% | ||||||||||||||
2028 | 3,687,608 | 12.3% | $49.66 | 10.1% | ||||||||||||||
2029 | 1,831,388 | 6.1% | $44.65 | 4.5% | ||||||||||||||
2030 | 2,446,190 | 8.1% | $42.70 | 5.8% | ||||||||||||||
2031 | 3,562,366 | 11.8% | $54.91 | 10.8% | ||||||||||||||
2032 | 886,704 | 2.9% | $57.83 | 2.8% | ||||||||||||||
2033 | 2,177,834 | 7.2% | $50.72 | 6.1% | ||||||||||||||
2034 | 2,727,148 | 9.1% | $66.91 | 10.1% | ||||||||||||||
2035 | 1,042,126 | 3.5% | $58.19 | 3.4% | ||||||||||||||
Thereafter | 6,868,641 | 22.9% | $82.42 | 31.3% | ||||||||||||||
2026 Contractual Lease Expirations (in RSF) | |||||||||||
Market | Leased | Negotiating/ Anticipating | Remaining Expiring Leases | Total(2) | Annual Rental Revenue (per RSF)(1) | ||||||
Greater Boston | 119,822 | 11,894 | 110,339 | 242,055 | $42.93 | ||||||
San Francisco Bay Area | 4,908 | 21,671 | 115,876 | 142,455 | 74.74 | ||||||
San Diego | — | — | 104,945 | 104,945 | 57.70 | ||||||
Seattle | 10,553 | 12,908 | 39,002 | 62,463 | 24.74 | ||||||
Maryland | 8,155 | — | 48,302 | 56,457 | 26.82 | ||||||
Research Triangle | 41,518 | 11,913 | 19,783 | 73,214 | 43.58 | ||||||
New York City | — | — | 36,501 | 36,501 | 103.49 | ||||||
Texas | — | — | — | — | — | ||||||
Non-cluster/other markets | — | — | 20,213 | 20,213 | 57.70 | ||||||
Subtotal | 184,956 | 58,386 | 494,961 | 738,303 | 51.86 | ||||||
Key lease expirations with expected downtime | 17,271 | 81,642 | 648,470 | 747,383 | (3) | 59.77 | |||||
Total | 202,227 | 140,028 | 1,143,431 | 1,485,686 | $55.84 | ||||||
Percentage of expiring leases | 14% | 9% | 77% | 100% | |||||||
2027 Contractual Lease Expirations (in RSF) | |||||||||||
Market | Leased | Negotiating/ Anticipating | Remaining Expiring Leases | Total | Annual Rental Revenue (per RSF)(1) | ||||||
Greater Boston | 50,375 | 24,386 | 110,518 | 185,279 | $67.27 | ||||||
San Francisco Bay Area | 1,873 | 8,927 | 183,000 | 193,800 | 72.78 | ||||||
San Diego | — | 62,415 | 335,515 | 397,930 | 45.00 | ||||||
Seattle | 9,435 | 93,839 | 305,254 | 408,528 | 47.30 | ||||||
Maryland | — | — | 191,188 | 191,188 | 30.63 | ||||||
Research Triangle | 30,696 | — | 283,614 | 314,310 | 34.13 | ||||||
New York City | — | — | 100,787 | 100,787 | 97.97 | ||||||
Texas | — | 65,551 | 26,160 | 91,711 | 26.10 | ||||||
Non-cluster/other markets | — | — | — | — | — | ||||||
Subtotal | 92,379 | 255,118 | 1,536,036 | 1,883,533 | 49.28 | ||||||
Key lease expirations with expected downtime | — | — | 1,484,464 | 1,484,464 | (4) | 65.64 | |||||
Total | 92,379 | 255,118 | 3,020,500 | 3,367,997 | $56.51 | ||||||
Percentage of expiring leases | 3% | 8% | 89% | 100% | |||||||


Progress on 2027 Key Lease Expirations | ||||
36% | 61% | 533K RSF | ||
of ARR Relocating to ARE Development/ Redevelopment Projects | Average RSF Expansion by Relocating Tenants | Under Negotiation (36% of Expiring RSF) | ||
Remaining Lease Term(1) (in Years) | Aggregate RSF | Annual Rental Revenue(1) | Percentage of Annual Rental Revenue(1) | Investment-Grade Credit Ratings | Average Market Cap (in billions) | |||||||||||||||||||
Tenant | Moody’s | S&P | ||||||||||||||||||||||
1 | Bristol-Myers Squibb Company | 5.9 | 1,226,762 | $ | 107,021 | 5.8% | A2 | A | $102.8 | |||||||||||||||
2 | Eli Lilly and Company | 9.2 | 1,053,592 | 92,049 | 5.0 | Aa3 | A+ | $826.6 | ||||||||||||||||
3 | Moderna, Inc. | 12.7 | 462,100 | 71,571 | 3.9 | — | — | $12.4 | ||||||||||||||||
4 | AstraZeneca PLC | 5.9 | 611,326 | 55,480 | 3.0 | A1 | A+ | $255.3 | ||||||||||||||||
5 | Takeda Pharmaceutical Company Limited | 10.6 | 386,111 | 41,673 | 2.3 | Baa1 | BBB+ | $48.9 | ||||||||||||||||
6 | Eikon Therapeutics, Inc.(2) | 13.2 | 299,638 | 38,907 | 2.1 | — | — | $0.7 | ||||||||||||||||
7 | Illumina, Inc. | 5.6 | 792,687 | 29,977 | 1.6 | Baa3 | BBB | $16.6 | ||||||||||||||||
8 | United States Government | 4.4 | 414,499 | 29,334 | (3) | 1.6 | Aaa | AA+ | $— | |||||||||||||||
9 | Uber Technologies, Inc. | 56.5 | (4) | 1,009,188 | 27,865 | 1.5 | Baa1 | BBB | $178.6 | |||||||||||||||
10 | Boston Children's Hospital | 11.0 | 309,231 | 26,294 | 1.4 | Aa2 | AA | $— | ||||||||||||||||
11 | Novartis AG | 2.2 | (5) | 321,743 | 25,111 | 1.4 | Aa3 | AA- | $273.6 | |||||||||||||||
12 | Sanofi | 4.8 | 267,278 | 22,045 | 1.2 | Aa3 | AA | $119.9 | ||||||||||||||||
13 | Alphabet Inc. | 2.1 | 418,600 | 21,837 | 1.2 | Aa2 | AA+ | $2,946.3 | ||||||||||||||||
14 | New York University | 6.3 | 218,983 | 21,073 | 1.1 | Aa2 | AA- | $— | ||||||||||||||||
15 | Massachusetts Institute of Technology | 3.8 | 242,428 | 20,529 | 1.1 | Aaa | AAA | $— | ||||||||||||||||
16 | Charles River Laboratories, Inc. | 9.4 | 238,938 | 20,045 | 1.1 | — | — | $8.1 | ||||||||||||||||
17 | Merck & Co., Inc. | 7.8 | 308,356 | 19,610 | 1.1 | Aa3 | A+ | $231.2 | ||||||||||||||||
18 | Vaxcyte, Inc. | 8.8 | 230,755 | 18,672 | 1.0 | — | — | $5.5 | ||||||||||||||||
19 | Altos Labs, Inc.(6) | 15.0 | 158,990 | 18,407 | 1.0 | — | — | $— | ||||||||||||||||
20 | Amgen Inc. | 9.7 | 317,157 | 18,181 | 1.0 | Baa1 | BBB+ | $167.7 | ||||||||||||||||
Total/weighted-average | 9.9 | (4) | 9,288,362 | $ | 725,681 | 39.4% | ||||||||||||||||||
RSF | Number of Properties | Annual Rental Revenue | ||||||||||||||||
Market | Operating | Development | Redevelopment | Total | % of Total | Total | % of Total | Per RSF | ||||||||||
Greater Boston | 9,338,588 | 566,673 | 1,361,372 | 11,266,633 | 29% | 63 | $697,286 | 38% | $89.09 | |||||||||
San Francisco Bay Area | 6,083,765 | 212,657 | 84,157 | 6,380,579 | 16 | 52 | 332,008 | 18 | 69.11 | |||||||||
San Diego | 6,225,980 | 893,525 | — | 7,119,505 | 18 | 61 | 295,434 | 15 | 53.67 | |||||||||
Seattle | 2,846,292 | 227,577 | — | 3,073,869 | 8 | 39 | 120,494 | 7 | 48.21 | |||||||||
Maryland | 3,676,566 | — | — | 3,676,566 | 9 | 47 | 153,371 | 8 | 45.94 | |||||||||
Research Triangle | 3,435,988 | — | — | 3,435,988 | 9 | 36 | 89,401 | 5 | 27.74 | |||||||||
New York City | 727,674 | — | — | 727,674 | 2 | 2 | 66,510 | 4 | 95.46 | |||||||||
Texas | 1,651,094 | — | 66,350 | 1,717,444 | 4 | 13 | 37,887 | 2 | 28.04 | |||||||||
Non-cluster/other markets(1) | 417,523 | — | — | 417,523 | 1 | 7 | 10,903 | 1 | 30.36 | |||||||||
Properties held for sale | 1,444,387 | — | — | 1,444,387 | 4 | 19 | 32,567 | 2 | 31.27 | |||||||||
North America | 35,847,857 | 1,900,432 | 1,511,879 | 39,260,168 | 100% | 339 | $1,835,861 | 100% | $59.91 | |||||||||
3,412,311 | ||||||||||||||||||
Operating Properties | Operating and Redevelopment Properties | |||||||||||
Market | 3/31/26 | 12/31/25 | 3/31/25 | 3/31/26 | 12/31/25 | 3/31/25 | ||||||
Greater Boston | 83.8% | (2) | 86.4% | 91.8% | 73.1% | 75.1% | 78.4% | |||||
San Francisco Bay Area | 87.6 | (2) | 90.9 | 90.3 | 86.4 | 89.4 | 86.3 | |||||
San Diego | 88.4 | (2) | 97.2 | 94.3 | 88.4 | 97.2 | 94.3 | |||||
Seattle | 87.8 | 88.4 | 91.5 | 87.8 | 88.4 | 91.5 | ||||||
Maryland | 92.3 | (3) | 93.6 | 94.1 | 92.3 | 93.6 | 94.1 | |||||
Research Triangle | 93.8 | (4) | 95.2 | 93.4 | 93.8 | 95.2 | 93.4 | |||||
New York City | 95.8 | 96.4 | 87.6 | 95.8 | 96.4 | 87.6 | ||||||
Texas | 81.8 | 79.9 | 82.1 | 78.7 | 76.5 | 78.9 | ||||||
Subtotal | 87.8 | 90.9 | 91.8 | 84.0 | 86.9 | 87.1 | ||||||
Canada | N/A | (1) | N/A | (1) | 94.6 | N/A | N/A | 82.4 | ||||
Non-cluster/other markets | 86.0 | 91.2 | 73.0 | 86.0 | 91.2 | 73.0 | ||||||
North America | 87.7% | (5) | 90.9% | 91.7% | 84.1% | 86.9% | 86.9% | |||||
Development and Redevelopment | |||||||||||||
Under Construction | |||||||||||||
Operating | 2Q26–4Q26 Stabilization | 2027–2028 Stabilization | Evaluating Business and Financial Strategy | Future | Subtotal | Total | |||||||
Square footage | |||||||||||||
Operating | 34,403,470 | — | — | — | — | — | 34,403,470 | ||||||
Future Class A/A+ development and redevelopment properties | — | 601,589 | 1,258,004 | 1,552,718 | 20,014,546 | 23,426,857 | 23,426,857 | ||||||
Future development and redevelopment square feet currently included in rental properties(1) | — | — | — | — | (1,516,872) | (1,516,872) | (1,516,872) | ||||||
Total square footage, excluding properties held for sale | 34,403,470 | 601,589 | 1,258,004 | 1,552,718 | 18,497,674 | 21,909,985 | 56,313,455 | ||||||
Properties held for sale | 1,444,387 | — | — | — | 1,619,425 | 1,619,425 | 3,063,812 | ||||||
Total square footage | 35,847,857 | 601,589 | 1,258,004 | 1,552,718 | 20,117,099 | 23,529,410 | 59,377,267 | ||||||
Investments in real estate | |||||||||||||
Gross book value as of March 31, 2026(2) | $28,135,300 | $629,966 | $1,130,851 | $1,356,515 | $3,971,142 | $7,088,474 | (3) | $35,223,774 | |||||
Properties held for sale | 423,335 | — | — | — | 230,905 | 230,905 | 654,240 | ||||||
Total gross investment in real estate, excluding properties held for sale | $27,711,965 | $629,966 | $1,130,851 | $1,356,515 | $3,740,237 | $6,857,569 | $34,569,534 | ||||||


Development/ Redevelopment Under Construction |
Land/Future Development |
Price (Our Share) | Gain on Sales of Real Estate | ||||
Property | |||||
Completed in April 2026 | $2,250 | $— | |||
Our share of pending dispositions subject to non-refundable deposits, signed letters of intent, and/or purchase and sale agreement negotiations | 149,106 | ||||
Completed and pending 2026 dispositions as of April 27, 2026 | 151,356 | ||||
Dispositions and sales of partial interests identified and in process(1) | 2,181,275 | ||||
Additional projected | 567,369 | ||||
$2,900,000 | |||||
2026 guidance range for dispositions and sales of partial interests | |||||
Midpoint | $2,900,000 | ||||
Weighted-average projected disposition date | August 2026 | ||||

Near-Term Deliveries | Intermediate-Term Deliveries | |||
2Q26–4Q26 | 2027–2028 | |||
$92M | $93M | |||
93% Leased/Negotiating | 68% Leased/Negotiating | |||
601,589 RSF | 1.3 million RSF | |||
99 Coolidge Avenue | 10075 Barnes Canyon Road | 8800 Technology Forest Place | ||
Greater Boston/ Cambridge/Inner Suburbs | San Diego/Sorrento Mesa | Texas/Greater Houston | ||
146,147 RSF | 253,079 RSF | 57,042 RSF | ||
100% Occupancy | 80% Occupancy | 100% Occupancy | ||
![]() | ![]() | ![]() |
Property/Market/Submarket | 1Q26 Delivery Date(1) | Our Ownership Interest | RSF Placed in Service | Occupancy Percentage(2) | Total Project | Unlevered Yields | ||||||||||||||||||||
Prior to 1/1/26 | 1Q26 | Total | Initial Stabilized | Initial Stabilized (Cash Basis) | ||||||||||||||||||||||
RSF | Investment | |||||||||||||||||||||||||
Development projects | ||||||||||||||||||||||||||
99 Coolidge Avenue/Greater Boston/Cambridge/Inner Suburbs | 1/27/26 | 100% | 129,413 | 16,734 | 146,147 | 100% | 320,809 | $444,000 | 6.0% | 6.8% | ||||||||||||||||
10075 Barnes Canyon Road/San Diego/Sorrento Mesa | 3/31/26 | 50.0% | 171,469 | 81,610 | (3) | 253,079 | 80% | 253,079 | 314,000 | 5.5 | 5.7 | |||||||||||||||
Redevelopment projects | ||||||||||||||||||||||||||
8800 Technology Forest Place/Texas/Greater Houston | 2/5/26 | 100% | 50,094 | 6,948 | 57,042 | 100% | 123,392 | 112,000 | 6.3 | 6.0 | ||||||||||||||||
Weighted average/total | 1/28/26 | 350,976 | 105,292 | 456,268 | 697,280 | $870,000 | 5.9% | 6.3% | ||||||||||||||||||
99 Coolidge Avenue | 50 and 60 Sylvan Road(1) | 1450 Owens Street | ||
Greater Boston/ Cambridge/Inner Suburbs | Greater Boston/Route 128 | San Francisco Bay Area/ Mission Bay | ||
174,662 RSF | 267,015 RSF | 212,657 RSF | ||
84% Leased/Negotiating | 74% Leased/Negotiating | 51% Leased/Negotiating | ||
![]() | ![]() | ![]() |
269 East Grand Avenue | 4135 Campus Point Court | 10200 Campus Point Drive | 701 Dexter Avenue North | ||||
San Francisco Bay Area/ South San Francisco | San Diego/ University Town Center | San Diego/ University Town Center | Seattle/Lake Union | ||||
84,157 RSF | 426,927 RSF | 466,598 RSF | 227,577 RSF | ||||
40% Leased/Negotiating | 100% Leased | 100% Leased | 23% Leased/Negotiating | ||||
![]() | ![]() | ![]() | ![]() |
Property/Market/Submarket | Located on Mega- campus | Square Footage | Percentage | Occupancy(1) | ||||||||||||||||||
Dev/ Redev | In Service | CIP | Total | Leased | Leased/ Negotiating | Initial | Stabilized | |||||||||||||||
Under construction | ||||||||||||||||||||||
2Q26–4Q26 stabilization | ||||||||||||||||||||||
99 Coolidge Avenue/Greater Boston/Cambridge/Inner Suburbs | X | Dev | 146,147 | 174,662 | 320,809 | 84% | 84% | 4Q23 | 4Q26 | |||||||||||||
4135 Campus Point Court/San Diego/University Town Center | X | Dev | — | 426,927 | 426,927 | 100 | 100 | 3Q26 | 3Q26 | |||||||||||||
146,147 | 601,589 | 747,736 | 93 | 93 | ||||||||||||||||||
2027–2028 stabilization | ||||||||||||||||||||||
50 and 60 Sylvan Road/Greater Boston/Route 128 | X | Redev | — | 267,015 | 267,015 | 74 | 74 | 4Q26 | 2027 | |||||||||||||
1450 Owens Street/San Francisco Bay Area/Mission Bay | X | Dev | — | 212,657 | 212,657 | 51 | 51 | 2027 | 2027 | |||||||||||||
269 East Grand Avenue/San Francisco Bay Area/South San Francisco | X | Redev | — | 84,157 | 84,157 | 40 | 40 | 2H26 | 2027 | |||||||||||||
10200 Campus Point Drive/San Diego/University Town Center(2) | X | Dev | — | 466,598 | 466,598 | 100 | 100 | 2028 | 2028 | |||||||||||||
701 Dexter Avenue North/Seattle/Lake Union | X | Dev | — | 227,577 | 227,577 | 23 | 23 | 3Q26 | 2027 | |||||||||||||
— | 1,258,004 | 1,258,004 | 68 | 68 | ||||||||||||||||||
Total | 146,147 | 1,859,593 | 2,005,740 | 77% | 77% | |||||||||||||||||
Evaluating business and financial strategy with earliest potential lab delivery in 2028(3) | ||||||||||||||||||||||
311 Arsenal Street/Greater Boston/Cambridge/Inner Suburbs | X | Redev | 56,904 | 333,758 | 390,662 | 9% | 28% | |||||||||||||||
421 Park Drive/Greater Boston/Fenway | X | Dev | — | 392,011 | 392,011 | 13 | 13 | |||||||||||||||
40 Sylvan Road/Greater Boston/Route 128 | X | Redev | — | 329,049 | 329,049 | — | — | |||||||||||||||
3000 Minuteman Road/Greater Boston/Other | X | Redev | — | 431,550 | 431,550 | — | 37 | |||||||||||||||
8800 Technology Forest Place/Texas/Greater Houston | Redev | 57,042 | 66,350 | 123,392 | 46 | 46 | ||||||||||||||||
113,946 | 1,552,718 | 1,666,664 | 9% | 23% | ||||||||||||||||||
Our Ownership Interest | At 100% | Unlevered Yields | |||||||||||||||||
Property/Market/Submarket | In Service | CIP | Cost to Complete | Total at Completion | Initial Stabilized | Initial Stabilized (Cash Basis) | |||||||||||||
Under construction | |||||||||||||||||||
2Q26–4Q26 stabilization with 93% leased/negotiating | |||||||||||||||||||
99 Coolidge Avenue/Greater Boston/Cambridge/Inner Suburbs | 100% | $203,361 | $185,307 | $55,332 | $444,000 | 6.0% | 6.8% | ||||||||||||
4135 Campus Point Court/San Diego/University Town Center | 57.2% | — | 444,659 | 79,341 | 524,000 | 9.8% | 6.2% | ||||||||||||
203,361 | 629,966 | ||||||||||||||||||
2027–2028 stabilization with 68% leased/negotiating(1) | |||||||||||||||||||
50 and 60 Sylvan Road/Greater Boston/Route 128 | 100% | — | 360,504 | TBD | |||||||||||||||
1450 Owens Street/San Francisco Bay Area/Mission Bay | 25.0% | — | 251,678 | ||||||||||||||||
269 East Grand Avenue/San Francisco Bay Area/South San Francisco | 100% | — | 121,604 | ||||||||||||||||
10200 Campus Point Drive/San Diego/University Town Center(2) | 57.2% | — | 76,310 | 583,690 | 660,000 | 7.3% | 6.5% | ||||||||||||
701 Dexter Avenue North/Seattle/Lake Union | 100% | — | 320,755 | TBD | |||||||||||||||
— | 1,130,851 | ||||||||||||||||||
Total | $203,361 | $1,760,817 | $1,020,000 | (3) | $2,990,000 | (3) | |||||||||||||
Our share of investment(3)(4) | $200,000 | $1,350,000 | $680,000 | $2,230,000 | |||||||||||||||
Evaluating business and financial strategy with earliest potential lab delivery in 2028(5) | |||||||||||||||||||
311 Arsenal Street/Greater Boston/Cambridge/Inner Suburbs | 100% | $28,081 | $310,025 | TBD | |||||||||||||||
421 Park Drive/Greater Boston/Fenway | 100% | — | 606,090 | ||||||||||||||||
40 Sylvan Road/Greater Boston/Route 128 | 100% | — | 229,568 | ||||||||||||||||
3000 Minuteman Road/Greater Boston/Other | 100% | — | 168,783 | ||||||||||||||||
8800 Technology Forest Place/Texas/Greater Houston | 100% | 65,564 | 42,049 | ||||||||||||||||
$93,645 | $1,356,515 | ||||||||||||||||||
Market Property/Submarket | Our Ownership Interest | Book Value | Development and Redevelopment Square Footage | |||||||||
Under Construction | Future | Total(1) | ||||||||||
Greater Boston | ||||||||||||
Megacampus: The Arsenal on the Charles/Cambridge/Inner Suburbs | 100% | $322,671 | 333,758 | 34,157 | 367,915 | |||||||
311 Arsenal Street | ||||||||||||
Megacampus: 480 Arsenal Way and 446, 458, and 500 Arsenal Street, and 99 Coolidge Avenue/Cambridge/ Inner Suburbs | 100% | 209,508 | 174,662 | 560,000 | 734,662 | |||||||
446, 458, and 500 Arsenal Street, and 99 Coolidge Avenue | ||||||||||||
Megacampus: Alexandria Center® for Life Science – Fenway/Fenway | 100% | 606,090 | 392,011 | — | 392,011 | |||||||
421 Park Drive | ||||||||||||
Megacampus: Alexandria Center® for Life Science – Waltham/Route 128 | 100% | 655,867 | 596,064 | 515,000 | 1,111,064 | |||||||
40, 50, and 60 Sylvan Road, and 35 Gatehouse Drive | ||||||||||||
Megacampus: 30, 200, and 3000 Minuteman Road/Other | 100% | 194,127 | 431,550 | 350,000 | 781,550 | |||||||
3000 Minuteman Road | ||||||||||||
Megacampus: Alexandria Technology Square®/Cambridge | 100% | 8,858 | — | 100,000 | 100,000 | |||||||
10 Necco Street/Seaport Innovation District | 100% | 107,101 | — | 175,000 | 175,000 | |||||||
215 Presidential Way/Route 128 | 100% | 6,816 | — | 112,000 | 112,000 | |||||||
Other development and redevelopment projects | 100% | 165,576 | — | 740,000 | 740,000 | |||||||
$2,276,614 | 1,928,045 | 2,586,157 | 4,514,202 | |||||||||
Refer to “Megacampus” under “Definitions and reconciliations” in Item 2 for additional information. (1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have future development or redevelopment opportunities. Upon expiration of existing in-place leases, we intend to demolish or redevelop the existing property subject to market conditions and leasing. Refer to “Investments in real estate” under “Definitions and reconciliations” in Item 2 for additional information, including development and redevelopment square feet currently included in rental properties. | ||||||||||||
Market Property/Submarket | Our Ownership Interest | Book Value | Development and Redevelopment Square Footage | |||||||||
Under Construction | Future | Total(1) | ||||||||||
San Francisco Bay Area | ||||||||||||
Megacampus: Alexandria Center® for Science and Technology – Mission Bay/Mission Bay | 25.0% | $251,678 | 212,657 | — | 212,657 | |||||||
1450 Owens Street | ||||||||||||
Megacampus: Alexandria Center® for Advanced Technologies – South San Francisco/South San Francisco | 100% | 128,259 | 84,157 | 90,000 | 174,157 | |||||||
211(2) and 269 East Grand Avenue | ||||||||||||
Megacampus: Alexandria Center® for Advanced Technologies – Tanforan/South San Francisco | 100% | 443,324 | — | 1,930,000 | 1,930,000 | |||||||
1122, 1150, and 1178 El Camino Real | ||||||||||||
Alexandria Center® for Life Science – Millbrae/South San Francisco | 48.6% | 162,361 | — | 348,401 | 348,401 | |||||||
201 and 231 Adrian Road and 30 Rollins Road | ||||||||||||
Megacampus: Alexandria Center® for Life Science – San Carlos/Greater Stanford | 100% | 493,425 | — | 1,497,830 | 1,497,830 | |||||||
960 Industrial Road, 987 and 1075 Commercial Street, and 888 Bransten Road | ||||||||||||
2100, 2200, 2300, and 2400 Geng Road/Greater Stanford | 100% | 128,360 | — | 240,000 | 240,000 | |||||||
1,607,407 | 296,814 | 4,106,231 | 4,403,045 | |||||||||
San Diego | ||||||||||||
Megacampus: Campus Point by Alexandria/University Town Center | 57.2% | (3) | 709,266 | 893,525 | 866,816 | 1,760,341 | ||||||
10010(4), 10140(4), and 10200 Campus Point Drive and 4135, 4165, 4224, and 4275(4) Campus Point Court | ||||||||||||
11255 and 11355 North Torrey Pines Road/Torrey Pines | 100% | 163,973 | — | 215,000 | 215,000 | |||||||
Megacampus: One Alexandria Square/Torrey Pines | 100% | 69,826 | — | 125,280 | 125,280 | |||||||
10975 and 10995 Torreyana Road | ||||||||||||
Megacampus: 5200 Illumina Way/University Town Center | 51.0% | 17,939 | — | 451,832 | 451,832 | |||||||
9625 Towne Centre Drive/University Town Center | 30.0% | 837 | — | 100,000 | 100,000 | |||||||
Megacampus: Sequence District by Alexandria/Sorrento Mesa | 100% | 49,696 | — | 1,661,915 | 1,661,915 | |||||||
6290, 6310, 6340, 6350, and 6450 Sequence Drive | ||||||||||||
Megacampus: SD Tech by Alexandria/Sorrento Mesa | 50.0% | 127,187 | — | 493,845 | 493,845 | |||||||
9805 Scranton Road and 10065 Barnes Canyon Road | ||||||||||||
4075 Sorrento Valley Boulevard/Sorrento Valley | 100% | 29,598 | — | 144,000 | 144,000 | |||||||
Other development and redevelopment projects | (2) | 78,404 | — | 475,000 | 475,000 | |||||||
$1,246,726 | 893,525 | 4,533,688 | 5,427,213 | |||||||||
Refer to “Megacampus” under “Definitions and reconciliations” in Item 2 for additional information. (1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have future development or redevelopment opportunities. Upon expiration of existing in-place leases, we intend to demolish or redevelop the existing property subject to market conditions and leasing. Refer to “Investments in real estate” under “Definitions and reconciliations” in Item 2 for additional information, including development and redevelopment square feet currently included in rental properties. (2)Includes a property in which we own a partial interest through a real estate joint venture. Refer to Note 4 – “Consolidated and unconsolidated real estate joint ventures” to our unaudited consolidated financial statements in Item 1 for additional details. (3)The noncontrolling interest share of our real estate joint venture partner is anticipated to decrease to 25%, as we expect to fund the majority of future construction costs at the campus until our ownership interest increases to 75%, after which future capital would be contributed pro rata with our partner. (4)We have a 100% interest in this property. | ||||||||||||
Market Property/Submarket | Our Ownership Interest | Book Value | Development and Redevelopment Square Footage | |||||||||
Under Construction | Future | Total(1) | ||||||||||
Seattle | ||||||||||||
Megacampus: Alexandria Center® for Advanced Technologies – South Lake Union/Lake Union | (2) | $617,648 | 227,577 | 1,057,400 | 1,284,977 | |||||||
601 and 701 Dexter Avenue North and 800 Mercer Street | ||||||||||||
1010 4th Avenue South/SoDo | 100% | 63,523 | — | 544,825 | 544,825 | |||||||
410 West Harrison Street/Elliott Bay | 100% | 25,224 | — | 91,000 | 91,000 | |||||||
Megacampus: Alexandria Center® for Advanced Technologies – Canyon Park/Bothell | 100% | 20,692 | — | 230,000 | 230,000 | |||||||
21660 20th Avenue Southeast | ||||||||||||
Other development and redevelopment projects | 100% | 157,385 | — | 706,087 | 706,087 | |||||||
884,472 | 227,577 | 2,629,312 | 2,856,889 | |||||||||
Maryland | ||||||||||||
Megacampus: Alexandria Center® for Life Science – Shady Grove/Rockville | 100% | 28,803 | — | 296,000 | 296,000 | |||||||
9830 Darnestown Road | ||||||||||||
28,803 | — | 296,000 | 296,000 | |||||||||
Research Triangle | ||||||||||||
Megacampus: Alexandria Center® for Life Science – Durham/Research Triangle | 100% | 167,871 | — | 2,060,000 | 2,060,000 | |||||||
Megacampus: Alexandria Center® for Advanced Technologies and AgTech – Research Triangle/Research Triangle | 100% | 115,384 | — | 1,170,000 | 1,170,000 | |||||||
4 and 12 Davis Drive | ||||||||||||
Megacampus: Alexandria Center® for Sustainable Technologies/Research Triangle | 100% | 56,960 | — | 750,000 | 750,000 | |||||||
120 TW Alexander Drive, 2752 East NC Highway 54, and 10 South Triangle Drive | ||||||||||||
Other development and redevelopment projects | 100% | 1,647 | — | 25,000 | 25,000 | |||||||
341,862 | — | 4,005,000 | 4,005,000 | |||||||||
New York City | ||||||||||||
Megacampus: Alexandria Center® for Life Science – New York City/New York City | 100% | 180,617 | — | 550,000 | (3) | 550,000 | ||||||
$180,617 | — | 550,000 | 550,000 | |||||||||
Refer to “Megacampus” under “Definitions and reconciliations” in Item 2 for additional information. (1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have inherent future development or redevelopment opportunities. Upon expiration of existing in-place leases, we intend to demolish or redevelop the existing property. Refer to “Investments in real estate” under “Definitions and reconciliations” for additional information, including development and redevelopment square feet currently included in rental properties. (2)We have a 100% interest in 601 and 701 Dexter Avenue North aggregating 415,977 RSF and a 60% interest in the future development project at 800 Mercer Street aggregating 869,000 RSF. (3)During the three months ended September 30, 2024, we filed a lawsuit against the New York City Health + Hospitals Corporation and the New York City Economic Development Corporation for fraud and breach of contract concerning our option to ground lease a land parcel to develop a future world-class life science building within the Alexandria Center® for Life Science – New York City Megacampus. Refer to “Legal proceedings” in Item 1 under Part II – Other Information for additional details. | ||||||||||||
Market Property/Submarket | Our Ownership Interest | Book Value | Development and Redevelopment Square Footage | |||||||||
Under Construction | Future | Total(1) | ||||||||||
Texas | ||||||||||||
Alexandria Center® for Advanced Technologies at The Woodlands/Greater Houston | 100% | $45,105 | 66,350 | 116,405 | 182,755 | |||||||
8800 Technology Forest Place | ||||||||||||
1001 Trinity Street and 1020 Red River Street/Austin | 100% | 137,652 | — | 250,010 | 250,010 | |||||||
Other development and redevelopment projects | 100% | 60,808 | — | 344,000 | 344,000 | |||||||
243,565 | 66,350 | 710,415 | 776,765 | |||||||||
Other development and redevelopment projects | 100% | 47,503 | — | 597,743 | 597,743 | |||||||
Total pipeline as of March 31, 2026, excluding properties held for sale | 6,857,569 | 3,412,311 | 20,014,546 | 23,426,857 | ||||||||
Properties held for sale | 230,905 | — | 1,619,425 | 1,619,425 | ||||||||
Total pipeline as of March 31, 2026 | $7,088,474 | (2) | 3,412,311 | 21,633,971 | 25,046,282 | |||||||
Three Months Ended March 31, 2026 | |||
Percentage change in net operating income over comparable period from prior year | (11.9)% | (1) | |
Percentage change in net operating income (cash basis) over comparable period from prior year | (11.7)% | (1) | |
Operating margin | 65% | ||
Number of Same Properties | 294 | ||
RSF | 31,965,127 | ||
Occupancy – current-period average | 88.9% | ||
Occupancy – same-period prior-year average | 94.0% |
Development and redevelopment – under construction | Properties | |
99 Coolidge Avenue | 1 | |
1450 Owens Street | 1 | |
421 Park Drive | 1 | |
4135 Campus Point Court | 1 | |
701 Dexter Avenue North | 1 | |
10200 Campus Point Drive | 1 | |
40, 50, and 60 Sylvan Road | 3 | |
269 East Grand Avenue | 1 | |
8800 Technology Forest Place | 1 | |
311 Arsenal Street | 1 | |
3000 Minuteman Road | 2 | |
14 | ||
Development – placed into service after January 1, 2025 | ||
230 Harriet Tubman Way | 1 | |
500 North Beacon Street and 4 Kingsbury Avenue | 2 | |
10935, 10945, and 10955 Alexandria Way | 3 | |
10075 Barnes Canyon Road | 1 | |
7 | ||
Acquisitions after January 1, 2025 | ||
Other | 2 | |
2 | ||
Unconsolidated real estate JVs | 3 | |
Properties held for sale | 19 | |
Total properties excluded from Same Properties | 45 | |
Same Properties | 294 | |
Total properties in North America as of March 31, 2026 | 339 |
Three Months Ended March 31, | |||||||||
2026 | 2025 | $ Change | % Change | ||||||
Income from rentals: | |||||||||
Same Properties | $431,442 | $473,233 | $(41,791) | (8.8)% | |||||
Non-Same Properties | 43,344 | 78,879 | (35,535) | (45.1) | |||||
Rental revenues | 474,786 | 552,112 | (77,326) | (14.0) | |||||
Same Properties | 166,149 | 165,419 | 730 | 0.4 | |||||
Non-Same Properties | 12,078 | 25,644 | (13,566) | (52.9) | |||||
Tenant recoveries | 178,227 | 191,063 | (12,836) | (6.7) | |||||
Income from rentals | 653,013 | 743,175 | (90,162) | (12.1) | |||||
Same Properties | 250 | 303 | (53) | (17.5) | |||||
Non-Same Properties | 17,759 | 14,680 | 3,079 | 21.0 | |||||
Other income | 18,009 | 14,983 | 3,026 | 20.2 | |||||
Same Properties | 597,841 | 638,955 | (41,114) | (6.4) | |||||
Non-Same Properties | 73,181 | 119,203 | (46,022) | (38.6) | |||||
Total revenues | 671,022 | 758,158 | (87,136) | (11.5) | |||||
Same Properties | 208,056 | 196,587 | 11,469 | 5.8 | |||||
Non-Same Properties | 16,086 | 29,808 | (13,722) | (46.0) | |||||
Rental operations | 224,142 | 226,395 | (2,253) | (1.0) | |||||
Same Properties | 389,785 | 442,368 | (52,583) | (11.9) | |||||
Non-Same Properties | 57,095 | 89,395 | (32,300) | (36.1) | |||||
Net operating income | $446,880 | $531,763 | $(84,883) | (16.0)% | |||||
Net operating income – Same Properties | $389,785 | $442,368 | $(52,583) | (11.9)% | |||||
Straight-line rent revenue | (13,114) | (15,469) | 2,355 | (15.2) | |||||
Amortization of acquired below-market leases and deferred revenue related to tenant-funded and -built landlord improvements | (10,063) | (11,558) | 1,495 | (12.9) | |||||
Net operating income – Same Properties (cash basis) | $366,608 | $415,341 | $(48,733) | (11.7)% | |||||
Three Months Ended March 31, | ||||||
Component | 2026 | 2025 | Change | |||
Gross interest | $134,557 | $130,941 | $3,616 | |||
Capitalized interest | (69,973) | (80,065) | 10,092 | |||
Interest expense | $64,584 | $50,876 | $13,708 | |||
Average debt balance outstanding(1) | $12,901,002 | $12,815,953 | $85,049 | |||
Weighted-average annual interest rate(2) | 4.2% | 4.1% | 0.1% | |||
Component | Interest Rate(1) | Effective Date | Change | |||||
Increases in interest incurred due to: | ||||||||
Issuances of debt: | ||||||||
$550 million of unsecured senior notes payable due 2035 | 5.66% | February 2025 | $3,544 | |||||
$750 million of unsecured senior notes payable due 2036 | 5.41% | February 2026 | 3,956 | |||||
Higher average outstanding balances under commercial paper program and/or unsecured senior line of credit | 13,173 | |||||||
Total increases | 20,673 | |||||||
Decreases in interest incurred due to: | ||||||||
Repayments of debt: | ||||||||
Repaid $525 million of $1 billion of unsecured senior notes due 2052 | 3.64% | February 2026 | (2,537) | |||||
Repaid $498 million of $850 million of unsecured senior notes due 2051 | 3.09% | February 2026 | (2,036) | |||||
Repaid $309 million of $700 million of unsecured senior notes due 2050 | 3.91% | February 2026 | (1,678) | |||||
$300 million of unsecured senior notes payable due 2026 | 4.50% | January 2026 | (2,748) | |||||
$600 million of unsecured senior notes payable due 2025 | 3.62% | April 2025 | (5,219) | |||||
Secured notes payable | 7.18% | August 2025 | (2,658) | |||||
Other decrease in interest | (181) | |||||||
Total decreases | (17,057) | |||||||
Change in gross interest | 3,616 | |||||||
Decrease in capitalized interest | 10,092 | |||||||
Total change in interest expense | $13,708 | |||||||
Three Months Ended March 31, 2026 | Projected Midpoint for Year Ending December 31, 2026 | ||||||||
Construction of Class A/A+ properties: | |||||||||
Active construction projects | |||||||||
Development and redevelopment under construction(1) | $ | 184,054 | $ | 1,445,000 | |||||
Future pipeline pre-construction | |||||||||
Primarily Megacampus expansion pre-construction work (entitlement, design, and site work) | 56,610 | 210,000 | (2) | ||||||
Revenue- and non-revenue-enhancing capital expenditures(3) | 164,382 | 510,000 | (4) | ||||||
Construction spending (before contributions from noncontrolling interests or tenants) | 405,046 | 2,165,000 | |||||||
Contributions from noncontrolling interests (consolidated real estate joint ventures) | (23,804) | (100,000) | (5) | ||||||
Tenant-funded and -built landlord improvements | (2,694) | (315,000) | |||||||
Total construction spending | $ | 378,548 | $ | 1,750,000 | |||||
2026 guidance range for construction spending | $1,500,000 – $2,000,000 | ||||||||
Projected timing | Amount(1) | |
April 1, 2026 through December 31, 2026 | $76,000 | |
2027 and beyond | 44,000 | |
Total | $120,000 | |
Average Real Estate Basis Capitalized | ||||||
Amount | Percentage | |||||
Construction of Class A/A+ properties: | ||||||
Development and redevelopment of projects under construction and repositioning projects: | ||||||
2026 stabilization | $330,399 | |||||
2027–2028 stabilization | 768,594 | |||||
Evaluating business and financial strategy(1) | 1,277,710 | |||||
Repositioning and smaller redevelopment projects(2) | 1,538,022 | |||||
3,914,725 | 57% | |||||
Land/future development projects with critical key pre-construction milestones through: | ||||||
2026(3) | 1,159,948 | |||||
2027(3) | 567,606 | |||||
2028 and beyond(4) | 1,217,819 | |||||
2,945,373 | 43 | |||||
Total average real estate basis capitalized(5) | $6,860,098 | 100% | ||||
Projected 2026 Funds From Operations per Share Attributable to Alexandria’s Common Stockholders – Diluted | As of 4/27/26 | As of 1/26/26 | Key Changes | |||||
Funds from operations per share and funds from operations per share, as adjusted(1) | $6.30 to $6.50 | $6.25 to $6.55 | No change to midpoint; range narrowed by 10 cents | |||||
Midpoint | $6.40 | $6.40 | ||||||
Key Credit Metric Targets | As of 4/27/26 | As of 1/26/26 | Key Changes | |||
Net debt and preferred stock to Adjusted EBITDA – fourth quarter of 2026 annualized | 5.6x to 6.2x | 5.6x to 6.2x | No Change | |||
Fixed-charge coverage ratio – fourth quarter of 2026 annualized | 3.6x to 4.1x | 3.6x to 4.1x | ||||
Key Sources and Uses of Capital (In millions) | As of 4/27/26 | Certain Completed Items | As of 1/26/26 Midpoint | ||||||||
Range | Midpoint | ||||||||||
Sources of capital: | |||||||||||
Reduction in debt | $(1,075) | $(2,275) | $(1,675) | See below | $(1,675) | ||||||
Net cash provided by operating activities, as adjusted | 475 | 575 | 525 | 525 | |||||||
Dispositions and sales of partial interests(1) | 2,100 | 3,700 | 2,900 | (1) | 2,900 | ||||||
Total sources of capital | $1,500 | $2,000 | $1,750 | $1,750 | |||||||
Uses of capital: | |||||||||||
Construction | $1,500 | $2,000 | $1,750 | $1,750 | |||||||
Total uses of capital | $1,500 | $2,000 | $1,750 | $1,750 | |||||||
Reduction in debt (included above): | |||||||||||
Repayment of secured notes payable with 2026 maturities(2) | $(650) | $(650) | $(650) | $(650) | (650) | ||||||
Tender offers for partial principal repayments of unsecured senior notes payable(3) | (952) | (952) | (952) | $(952) | — | ||||||
Issuance of unsecured senior notes payable(3) | 750 | 750 | 750 | $750 | — | ||||||
Unsecured senior line of credit, commercial paper program, and other | (223) | (1,423) | (823) | (1,025) | |||||||
Reduction in debt | $(1,075) | $(2,275) | $(1,675) | $(1,675) | |||||||
Key Assumptions(1) (Dollars in millions) | As of 4/27/26 | As of 1/26/26 | Key Changes to Midpoint | |||||||
Low | High | Low | High | |||||||
Occupancy of operating properties as of December 31, 2026 | 86.2% | (2) | 87.8% | (2) | 87.7% | 89.3% | 150 bps reduction(3) | |||
Same property performance: | ||||||||||
Net operating income | (10.5)% | (2) | (8.5)% | (2) | (9.5)% | (7.5)% | 100 bps reduction(3) | |||
Net operating income (cash basis) | (10.5)% | (2) | (8.5)% | (2) | (9.5)% | (7.5)% | 100 bps reduction(3) | |||
Lease renewals and re-leasing of space: | ||||||||||
Rental rate changes | (9.0)% | (1.0)% | (2.0)% | 6.0% | 700 bps reduction(4) | |||||
Rental rate changes (cash basis) | (15.0)% | (7.0)% | (12.0)% | (4.0)% | 300 bps reduction(4) | |||||
Straight-line rent revenue | $55 | $85 | $65 | $95 | $10 million reduction(4) | |||||
General and administrative expenses | $134 | $154 | $134 | $154 | No Change | |||||
Capitalization of interest | $225 | $265 | $225 | $275 | $5 million reduction(5) | |||||
Interest expense | $240 | $280 | $230 | $280 | $5 million increase(5) | |||||
Realized gains on non-real estate investments(6) | $60 | $90 | $60 | $90 | No Change | |||||
Occupancy of Operating Properties | Same Property Performance | Lease Renewals and Re-leasing of Space | Straight-Line Rent Revenue | ||||||||||||||
Key Drivers of Changes to Certain 2026 Projected Operating Metrics and Assumptions | As of December 31, 2026 | Benefit From Potential Held For Sale Assets(1) | Net Operating Income Changes (Cash Basis) | Net Operating Income Changes | Benefit From Potential Held For Sale Assets(1) | Rental Rate Changes | Rental Rate Changes (Cash Basis) | ||||||||||
Guidance ranges as of 1/26/26 | 87.7% to 89.3% | 2% | (9.5)% to (7.5)% | (9.5)% to (7.5)% | 3% | (2.0)% to 6.0% | (12.0)% to (4.0)% | $65M to $95M | |||||||||
Changes to range of properties that could potentially be sold during 2026 that were assumed in prior 2026 guidance(1) | (1.3) | (1) | (1.0) | (1.0) | (1) | — | — | — | |||||||||
Primarily related to the re-lease of two spaces subject to tenant wind-downs(2) | (0.2) | — | — | — | — | (7.0) | (3.0) | (10) | (3) | ||||||||
Total changes to 2026 guidance midpoints | (1.5) | (1) | (1.0) | (1.0) | (1) | (7.0) | (3.0) | (10) | |||||||||
Guidance ranges as of 4/27/26 | 86.2% to 87.8% | 1% | (10.5)% to (8.5)% | (10.5)% to (8.5)% | 2% | (9.0)% to (1.0)% | (15.0)% to (7.0)% | $55M to $85M | |||||||||

Consolidated Real Estate Joint Ventures | ||||||||
Property/Market/Submarket | Noncontrolling Interest Share | Operating RSF at 100% | ||||||
50 and 60 Binney Street/Greater Boston/Cambridge/Inner Suburbs | 66.0% | 532,395 | ||||||
75/125 Binney Street/Greater Boston/Cambridge/Inner Suburbs | 60.0% | 388,270 | ||||||
100 and 225 Binney Street and 300 Third Street/Greater Boston/Cambridge/Inner Suburbs | 70.0% | 870,641 | ||||||
15 Necco Street/Greater Boston/Seaport Innovation District | 43.3% | 345,996 | ||||||
Alexandria Center® for Science and Technology – Mission Bay/San Francisco Bay Area/ Mission Bay(1) | 75.0% | 550,851 | ||||||
211 and 213 East Grand Avenue/San Francisco Bay Area/South San Francisco | 70.0% | 300,930 | ||||||
500 Forbes Boulevard/San Francisco Bay Area/South San Francisco | 90.0% | 155,685 | ||||||
Alexandria Center® for Life Science – Millbrae/San Francisco Bay Area/South San Francisco | 51.4% | 285,346 | ||||||
3215 Merryfield Row/San Diego/Torrey Pines | 70.0% | 170,523 | ||||||
Campus Point by Alexandria/San Diego/University Town Center(2)(3) | 42.8% | (4) | 1,159,770 | |||||
5200 Illumina Way/San Diego/University Town Center | 49.0% | 792,687 | ||||||
9625 Towne Centre Drive/San Diego/University Town Center | 70.0% | 163,648 | ||||||
SD Tech by Alexandria/San Diego/Sorrento Mesa(2)(5) | 50.0% | 1,051,752 | ||||||
Summers Ridge Science Park/San Diego/Sorrento Mesa(6) | 70.0% | 316,531 | ||||||
1201 and 1208 Eastlake Avenue East/Seattle/Lake Union | 70.0% | 206,134 | ||||||
400 Dexter Avenue North/Seattle/Lake Union | 70.0% | 290,754 | ||||||
800 Mercer Street/Seattle/Lake Union | 40.0% | — | (2) | |||||
Unconsolidated Real Estate Joint Ventures | ||||||||
Property/Market/Submarket | Our Ownership Share | Operating RSF at 100% | ||||||
1655 and 1725 Third Street/San Francisco Bay Area/Mission Bay | 10.0% | 586,208 | ||||||
101 West Dickman Street/Maryland/Beltsville | 58.4% | (7) | 135,958 | |||||
Maturity Date | Stated Rate | Interest Rate(1) | At 100% | Our Share | ||||||||||
Unconsolidated Joint Venture | Aggregate Commitment | Debt Balance(2) | ||||||||||||
101 West Dickman Street | 10/29/26 | SOFR+1.95% | (3) | 5.68% | $26,750 | $19,048 | 58.4% | |||||||
1655 and 1725 Third Street | 2/10/35 | 6.37% | 6.44% | 500,000 | 496,967 | 10.0% | ||||||||
$526,750 | $516,015 | |||||||||||||
Three Months Ended March 31, 2026 | ||||
Noncontrolling Interest Share of Consolidated Real Estate Joint Ventures | Our Share of Unconsolidated Real Estate Joint Ventures | |||
Total revenues | $97,212 | $3,006 | ||
Rental operations | (30,677) | (1,191) | ||
66,535 | 1,815 | |||
General and administrative | (622) | (22) | ||
Interest | (63) | (1,026) | ||
Depreciation and amortization of real estate assets | (29,473) | (914) | ||
Fixed returns allocated to redeemable noncontrolling interest(1) | 347 | — | ||
$36,724 | $(147) | |||
Straight-line rent and below-market lease revenue | $2,981 | $197 | ||
Funds from operations(2) | $66,197 | $767 | ||
As of March 31, 2026 | |||
Noncontrolling Interest Share of Consolidated Real Estate Joint Ventures | Our Share of Unconsolidated Real Estate Joint Ventures | ||
Investments in real estate | $3,261,264 | $88,793 | |
Cash, cash equivalents, and restricted cash | 111,509 | 1,648 | |
Other assets | 411,563 | 10,686 | |
Secured notes payable | — | (60,821) | |
Other liabilities | (154,688) | (9,786) | |
Redeemable noncontrolling interests | (9,234) | — | |
$3,620,414 | $30,520 | ||
Three Months Ended | ||||||
March 31, 2026 | March 31, 2025 | |||||
Realized gains: | ||||||
Realized gains | $18,198 | $29,333 | ||||
Impairment of non-real estate investments | (12,448) | (1) | (11,180) | |||
5,750 | 18,153 | |||||
Unrealized losses | (10,332) | (2) | (68,145) | (3) | ||
Investment loss | $(4,582) | $(49,992) | ||||
March 31, 2026 | December 31, 2025 | |||||||||
Investments | Cost | Unrealized Gains | Unrealized Losses | Carrying Amount | Carrying Amount | |||||
Publicly traded companies | $83,916 | $34,674 | $(16,514) | $102,076 | $94,928 | |||||
Entities that report NAV | 471,058 | 102,050 | (38,132) | 534,976 | 512,376 | |||||
Entities that do not report NAV: | ||||||||||
Entities with observable price changes | 82,128 | 54,780 | (10,991) | 125,917 | 123,238 | |||||
Entities without observable price changes | 405,567 | — | — | 405,567 | 413,324 | |||||
Investments accounted for under the equity method | N/A | N/A | N/A | 367,883 | 357,383 | |||||
March 31, 2026 | $1,042,669 | (4) | $191,504 | $(65,637) | $1,536,419 | $1,501,249 | ||||
December 31, 2025 | $1,010,488 | $184,434 | $(51,056) | $1,501,249 | ||||||
Public/Private Mix (Cost) | Tenant/Non-Tenant Mix (Cost) | |


Liquidity | Limited Outstanding Borrowings and Significant Availability on Unsecured Senior Line of Credit | ||||
$4.2B | (in millions) | ||||
![]() | |||||
(In millions) | |||||
Availability under our unsecured senior line of credit, net of amounts outstanding under our commercial paper program | $3,645 | ||||
Cash, cash equivalents, and restricted cash | 423 | ||||
Investments in publicly traded companies | 102 | ||||
Liquidity as of March 31, 2026 | $4,170 | ||||
Description | Stated Rate | Aggregate Commitments | Outstanding Balance | Remaining Commitments/ Liquidity | ||||
Availability under our unsecured senior line of credit, net of amounts outstanding under our commercial paper program | SOFR+0.835% | $5,000,000 | $1,355,271 | $3,644,729 | ||||
Cash, cash equivalents, and restricted cash | 423,385 | |||||||
Investments in publicly traded companies | 102,076 | |||||||
Liquidity as of March 31, 2026 | $4,170,190 |
Three Months Ended March 31, | |||||
2026 | 2025 | Change | |||
Net cash provided by operating activities | $196,624 | $207,949 | $(11,325) | ||
Net cash used in investing activities | $(584,810) | $(654,779) | $69,969 | ||
Net cash provided by financing activities | $258,003 | $370,775 | $(112,772) | ||
Three Months Ended March 31, | Change | ||||
2026 | 2025 | ||||
Sources of cash from investing activities: | |||||
Proceeds from sales of real estate | $— | $68,182 | $(68,182) | ||
Sales of and distributions from non-real estate investments | 35,000 | 12,691 | 22,309 | ||
Return of capital from unconsolidated real estate joint ventures | 113 | — | 113 | ||
35,113 | 80,873 | (45,760) | |||
Uses of cash for investing activities: | |||||
Additions to real estate | 545,999 | 645,841 | (99,842) | ||
Change in escrow deposits | — | 9,506 | (9,506) | ||
Investments in unconsolidated real estate joint ventures | 297 | 10,994 | (10,697) | ||
Additions to non-real estate investments | 73,627 | 69,311 | 4,316 | ||
619,923 | 735,652 | (115,729) | |||
Net cash used in investing activities | $584,810 | $654,779 | $(69,969) | ||
Three Months Ended March 31, | |||||
2026 | 2025 | Change | |||
Borrowings under secured notes payable | $— | $824 | $(824) | ||
Repayments of borrowings under secured notes payable | (8,892) | — | (8,892) | ||
Proceeds from issuance of unsecured senior notes payable | 747,592 | 548,532 | 199,060 | ||
Repayments of unsecured senior note payable | (1,252,203) | — | (1,252,203) | ||
Proceeds from issuances under commercial paper program | 12,319,811 | 2,700,000 | 9,619,811 | ||
Repayments of borrowings under commercial paper program | (11,318,040) | (2,400,000) | (8,918,040) | ||
Payments of loan fees | (8,814) | (5,406) | (3,408) | ||
Changes related to debt | 479,454 | 843,950 | (364,496) | ||
Contributions from and sales of noncontrolling interests | 18,065 | 54,409 | (36,344) | ||
Distributions to noncontrolling interests | (60,111) | (66,034) | 5,923 | ||
Purchases and redemptions of noncontrolling interests | (49,707) | (17,818) | (31,889) | ||
Repurchase of common stock | — | (208,187) | 208,187 | ||
Dividends on common stock | (123,752) | (229,987) | 106,235 | ||
Taxes paid related to net settlement of equity awards | (5,946) | (5,558) | (388) | ||
Net cash provided by financing activities | $258,003 | $370,775 | $(112,772) | ||
Three Months Ended March 31, 2026 | ||||
Average Debt Outstanding | Weighted-Average Interest Rate | |||
Long-term fixed-rate debt | $11,432,675 | 3.94% | ||
Short-term variable-rate unsecured senior line of credit and commercial paper program debt | 1,736,226 | 4.05 | ||
Blended average interest rate | 13,168,901 | 3.95 | ||
Loan fee amortization and annual facility fee related to unsecured senior line of credit | N/A | 0.13 | ||
Total/weighted average | $13,168,901 | 4.08% | ||
Covenant Ratios(1) | Requirement | March 31, 2026 | ||
Total Debt to Total Assets | Less than or equal to 60% | 32% | ||
Secured Debt to Total Assets | Less than or equal to 40% | —% | ||
Consolidated EBITDA(2) to Interest Expense | Greater than or equal to 1.5x | 7.7x | ||
Unencumbered Total Asset Value to Unsecured Debt | Greater than or equal to 150% | 302% |
Covenant Ratios(1) | Requirement | March 31, 2026 | ||
Leverage Ratio | Less than or equal to 60.0% | 34.5% | ||
Secured Debt Ratio | Less than or equal to 45.0% | —% | ||
Fixed-Charge Coverage Ratio | Greater than or equal to 1.50x | 3.23x | ||
Unsecured Interest Coverage Ratio | Greater than or equal to 1.75x | 6.93x |
Total | ||
Balance as of December 31, 2025 | $(29,395) | |
Other comprehensive loss before reclassifications | (1,518) | |
Reclassification adjustment for loss included in net income | (23) | |
Net other comprehensive loss | (1,541) | |
Balance as of March 31, 2026 | $(30,936) |
March 31, 2026 | December 31, 2025 | |||
Assets: | ||||
Cash, cash equivalents, and restricted cash | $71,915 | $127,100 | ||
Other assets | 182,017 | 173,303 | ||
Total assets | $253,932 | $300,403 | ||
Liabilities: | ||||
Unsecured senior notes payable | $11,166,009 | $12,047,394 | ||
Unsecured senior line of credit and commercial paper | 1,353,986 | 353,161 | ||
Other liabilities | 420,800 | 433,707 | ||
Total liabilities | $12,940,795 | $12,834,262 | ||
Three Months Ended March 31, 2026 | Year Ended December 31, 2025 | |||
Total revenues | $14,508 | $48,748 | ||
Total expenses | (100,208) | (350,655) | ||
Gain on early extinguishment of debt | 366,435 | — | ||
Net income (loss) | 280,735 | (301,907) | ||
Net income attributable to unvested restricted stock awards | (2,779) | (8,417) | ||
Net income (loss) attributable to Alexandria Real Estate Equities, Inc.’s common stockholders | $277,956 | $(310,324) | ||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Net income (loss) attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic and diluted | $358,874 | $(11,599) | ||
Depreciation and amortization of real estate assets | 303,296 | 339,381 | ||
Noncontrolling share of depreciation and amortization from consolidated real estate JVs | (29,473) | (33,411) | ||
Our share of depreciation and amortization from unconsolidated real estate JVs | 914 | 1,054 | ||
Gain on sales of real estate | — | (13,165) | ||
Impairment of real estate – rental properties and land | 5,499 | (1) | — | |
Allocation to unvested restricted stock awards | (2,181) | (686) | ||
Funds from operations attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted(2) | 636,929 | 281,574 | ||
Unrealized losses on non-real estate investments | 10,332 | 68,145 | ||
Impairment of non-real estate investments | 12,448 | (3) | 11,180 | |
Impairment of real estate | — | 32,154 | ||
Gain on early extinguishment of debt | (366,435) | (4) | — | |
Increase in provision for expected credit losses on financial instruments | — | 285 | ||
Allocation to unvested restricted stock awards | 2,674 | (1,329) | ||
Funds from operations attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted | $295,948 | $392,009 | ||
Three Months Ended March 31, | ||||
(Per share) | 2026 | 2025 | ||
Net income (loss) per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted | $2.10 | $(0.07) | ||
Depreciation and amortization of real estate assets | 1.61 | 1.80 | ||
Gain on sales of real estate | — | (0.08) | ||
Impairment of real estate – rental properties and land | 0.03 | — | ||
Allocation to unvested restricted stock awards | (0.01) | — | ||
Funds from operations per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted | 3.73 | 1.65 | ||
Unrealized losses on non-real estate investments | 0.06 | 0.40 | ||
Impairment of non-real estate investments | 0.07 | 0.07 | ||
Impairment of real estate | — | 0.19 | ||
Gain on early extinguishment of debt | (2.14) | — | ||
Allocation to unvested restricted stock awards | 0.01 | (0.01) | ||
Funds from operations per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted | $1.73 | $2.30 | ||
Weighted-average shares of common stock outstanding – diluted(1) | ||||
Earnings per share – diluted | 170,867 | 170,522 | ||
Funds from operations – diluted, per share | 170,867 | 170,599 | ||
Funds from operations – diluted, as adjusted, per share | 170,867 | 170,599 | ||
Three Months Ended March 31, 2026 | |||
Noncontrolling Interest Share of Consolidated Real Estate Joint Ventures | Our Share of Unconsolidated Real Estate Joint Ventures | ||
Net income (loss) | $36,724 | $(147) | |
Depreciation and amortization of real estate assets | 29,473 | 914 | |
Funds from operations | $66,197 | $767 | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Net income | $398,377 | $38,662 | |
Interest expense | 64,584 | 50,876 | |
Income taxes | 3,225 | 1,145 | |
Depreciation and amortization | 305,441 | 342,062 | |
Stock compensation expense | 11,032 | 10,064 | |
Gain on early extinguishment of debt | (366,435) | (1) | — |
Gain on sales of real estate | — | (13,165) | |
Unrealized losses on non-real estate investments | 10,332 | 68,145 | |
Impairment of real estate | 5,499 | 32,154 | |
Impairment of non-real estate investments | 12,448 | 11,180 | |
Decrease in provision for expected credit losses on financial instruments | — | 285 | |
Adjusted EBITDA | $444,503 | $541,408 | |
Total revenues | $671,022 | $758,158 | |
Adjusted EBITDA margin | 66% | 71% | |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Adjusted EBITDA | $444,503 | $541,408 | ||
Interest expense | $64,584 | $50,876 | ||
Capitalized interest | 69,973 | 80,065 | ||
Amortization of loan fees | (4,428) | (4,691) | ||
Amortization of debt discounts | (320) | (349) | ||
Cash interest and fixed charges | $129,809 | $125,901 | ||
Fixed-charge coverage ratio: | ||||
– quarter annualized | 3.4x | 4.3x | ||
– trailing 12 months | 3.8x | 4.4x | ||
March 31, 2026 | December 31, 2025 | ||
Total assets | $34,167,397 | $34,081,835 | |
Accumulated depreciation | 6,393,658 | 6,127,525 | |
Gross assets | $40,561,055 | $40,209,360 | |
Book Value | Percentage of Gross Assets | |||
Projects under active construction | $3,117,332 | 8% | ||
Future development projects(1) and land parcels primarily located in Megacampuses | 3,740,237 | 9 | ||
Total Class A/A+ development and redevelopment pipeline, excluding properties held for sale | 6,857,569 | 17 | ||
Properties held for sale – land parcels | 230,905 | 1 | ||
Total Class A/A+ development and redevelopment pipeline | $7,088,474 | 18% | ||
Dev/Redev | RSF of Lease Expirations Targeted for Development and Redevelopment | |||||||||
Property/Submarket | 2026 | 2027 | Thereafter(1) | Total | ||||||
Future projects: | ||||||||||
446, 458, and 500 Arsenal Street/Cambridge/Inner Suburbs | Dev | — | — | 116,623 | 116,623 | |||||
1122 and 1150 El Camino Real/South San Francisco | Dev | — | — | 375,232 | 375,232 | |||||
2100 Geng Road/Greater Stanford | Dev | — | — | 12,125 | 12,125 | |||||
960 Industrial Road/Greater Stanford | Dev | — | — | 112,590 | 112,590 | |||||
Campus Point by Alexandria/University Town Center | Dev | — | — | 96,805 | 96,805 | |||||
Sequence District by Alexandria/Sorrento Mesa | Dev/Redev | — | — | 555,754 | 555,754 | |||||
Canada | Redev | — | — | 247,743 | 247,743 | |||||
Total | — | — | 1,516,872 | 1,516,872 | ||||||
Annual Rental Revenue | Development and Redevelopment Pipeline RSF | |||
Megacampus | $1,414,438 | 16,919,119 | ||
Core and non-core | 388,856 | 4,990,866 | ||
Total | $1,803,294 | 21,909,985 | ||
Megacampus as a percentage of annual rental revenue and of total development and redevelopment pipeline RSF | 78% | 77% |
Three Months Ended March 31, | ||||
(in thousands) | 2026 | 2025 | ||
Net cash provided by operating activities | $196,624 | 207,949 | ||
Decreases in operating assets and liabilities | 143,523 | 220,294 | ||
Common stock dividends paid | (123,752) | (229,987) | ||
Distributions to noncontrolling interests | (60,111) | (66,034) | ||
Net cash provided by operating activities, as adjusted | $156,284 | $132,222 | ||
March 31, 2026 | December 31, 2025 | ||
Unsecured senior notes payable | $11,166,009 | $12,047,394 | |
Unsecured senior line of credit and commercial paper | 1,353,986 | 353,161 | |
Unamortized deferred financing costs | 69,071 | 74,314 | |
Cash and cash equivalents | (418,720) | (549,062) | |
Restricted cash | (4,665) | (4,693) | |
Preferred stock | — | — | |
Net debt and preferred stock | $12,165,681 | $11,921,114 | |
Adjusted EBITDA: | |||
– quarter annualized | $1,778,012 | $2,097,444 | |
– trailing 12 months | $2,044,906 | $2,141,811 | |
Net debt and preferred stock to Adjusted EBITDA: | |||
– quarter annualized | 6.8x | 5.7x | |
– trailing 12 months | 5.9x | 5.6x |
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Net income | $398,377 | $38,662 | ||
Equity in losses of unconsolidated real estate joint ventures | 147 | 507 | ||
General and administrative expenses | 34,685 | 30,675 | ||
Interest expense | 64,584 | 50,876 | ||
Depreciation and amortization | 305,441 | 342,062 | ||
Impairment of real estate | 5,499 | 32,154 | ||
Gain on early extinguishment of debt | (366,435) | — | ||
Gain on sales of real estate | — | (13,165) | ||
Investment loss | 4,582 | 49,992 | ||
Net operating income | 446,880 | 531,763 | ||
Straight-line rent revenue | (17,862) | (22,023) | ||
Amortization of deferred revenue related to tenant-funded and -built landlord improvements | (5,405) | (1,651) | ||
Amortization of acquired below-market leases | (5,615) | (15,222) | ||
Provision for expected credit losses on financial instruments | — | 285 | ||
Net operating income (cash basis) | $417,998 | $493,152 | ||
Net operating income (from above) | $446,880 | $531,763 | ||
Total revenues | $671,022 | $758,158 | ||
Operating margin | 67% | 70% | ||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Income from rentals | $653,013 | $743,175 | ||
Rental revenues | (474,786) | (552,112) | ||
Tenant recoveries | $178,227 | $191,063 | ||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Unencumbered net operating income | $446,880 | $530,691 | |
Encumbered net operating income | — | 1,072 | |
Total net operating income | $446,880 | $531,763 | |
Unencumbered net operating income as a percentage of total net operating income | 100.0% | 99.8% | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Basic shares for earnings per share | 170,598 | 170,522 | |
Unvested RSAs with forfeitable dividends | 269 | — | |
Diluted shares for earnings per share | 170,867 | 170,522 | |
Basic shares for funds from operations per share and funds from operations per share, as adjusted | 170,598 | 170,522 | |
Unvested RSAs with forfeitable dividends | 269 | 77 | |
Diluted shares for funds from operations per share and funds from operations per share, as adjusted | 170,867 | 170,599 | |
Weighted-average unvested RSAs with nonforfeitable dividends used in the allocations of net income, funds from operations, and funds from operations, as adjusted | 1,340 | 2,053 | |
As of | |||
March 31, 2026 | December 31, 2025 | ||
Annualized effect on future earnings due to variable-rate debt: | |||
Rate increase of 1% | $(4,706) | $(1,259) | |
Rate decrease of 1% | $4,706 | $1,259 | |
Effect on fair value of total consolidated debt: | |||
Rate increase of 1% | $(658,167) | $(746,058) | |
Rate decrease of 1% | $742,060 | $852,698 | |
As of | |||
March 31, 2026 | December 31, 2025 | ||
Equity price risk: | |||
Fair value increase of 10% | $116,854 | $114,387 | |
Fair value decrease of 10% | $(116,854) | $(114,387) | |
As of | |||
March 31, 2026 | December 31, 2025 | ||
Effect on potential future earnings due to foreign currency exchange rate: | |||
Rate increase of 10% | $290 | $182 | |
Rate decrease of 10% | $(290) | $(182) | |
Effect on the fair value of net investment in foreign subsidiaries due to foreign currency exchange rate: | |||
Rate increase of 10% | $35,164 | $35,306 | |
Rate decrease of 10% | $(35,164) | $(35,306) | |
Change in the fair value of cross-currency swap agreements designated as a net investment hedge(1): | |||
Rate increase of 10% (USD weakening) | $24,400 | $(24,600) | |
Rate decrease of 10% (USD strengthening) | $(24,400) | $24,600 | |
Exhibit Number | Exhibit Title | Incorporated by Reference to: | Date Filed | |||
3.1* | Form 10-Q | August 14, 1997 | ||||
3.2* | Form 10-Q | August 14, 1997 | ||||
3.3* | Form 8-K | May 12, 2017 | ||||
3.4* | Form 8-K | May 19, 2022 | ||||
3.5* | Form 10-Q | August 13, 1999 | ||||
3.6* | Form 8-K | February 10, 2000 | ||||
3.7* | Form 8-K | February 10, 2000 | ||||
3.8* | Form 8-A | January 18, 2002 | ||||
3.9* | Form 8-A | June 28, 2004 | ||||
3.10* | Form 8-K | March 25, 2008 | ||||
3.11* | Form 8-K | March 14, 2012 | ||||
3.12* | Form 8-K | May 12, 2017 | ||||
3.13* | Form 8-K | March 31, 2026 | ||||
3.14* | Form 8-K | December 9, 2024 | ||||
4.1* | Form 8-K | February 13, 2025 | ||||
4.2* | Form 8-K | February 25, 2026 | ||||
4.3* | Form 8-K | February 25, 2026 | ||||
22.1 | N/A | Filed herewith | ||||
31.1 | N/A | Filed herewith | ||||
31.2 | N/A | Filed herewith | ||||
31.3 | N/A | Filed herewith | ||||
32.0 | N/A | Filed herewith | ||||
101.1 | The following materials from the Company’s quarterly report on Form 10-Q for the quarterly period ended March 31, 2026, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025 (unaudited), (ii) Consolidated Statements of Operations for the three months ended March 31, 2026 and 2025 (unaudited), (iii) Consolidated Statements of Comprehensive Income for the three months ended March 31, 2026 and 2025 (unaudited), (iv) Consolidated Statements of Changes in Stockholders’ Equity and Noncontrolling Interests for the three months ended March 31, 2026 and 2025 (unaudited), (v) Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025 (unaudited), and (vi) Notes to Consolidated Financial Statements (unaudited) | N/A | Filed herewith | |||
104 | Cover Page Interactive Data File – the cover page from this Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 is formatted in Inline XBRL and contained in Exhibit 101.1 | N/A | Filed herewith |
ALEXANDRIA REAL ESTATE EQUITIES, INC. | |
/s/ Joel S. Marcus | |
Joel S. Marcus Executive Chairman (Principal Executive Officer) | |
/s/ Peter M. Moglia | |
Peter M. Moglia Chief Executive Officer and Chief Investment Officer (Principal Executive Officer) | |
/s/ Marc E. Binda | |
Marc E. Binda Chief Financial Officer and Treasurer (Principal Financial Officer) |